Jaap Jan Zwaginga
Professor Clinical Transfusion Medicine
- Name
- Prof.dr. J.J. Zwaginga
- Telephone
- +31 71 526 9111
- j.j.zwaginga@lumc.nl
- ORCID iD
- 0000-0003-1228-7769
Within the LUMC Jaap Jan Zwaginga is full professor in Clinical Transfusion Medicine, section leader of the Centre for Stem Cell and Cell therapy both within the department Immunohematology and Bloodtransfusion and chairman of the LUMC Blood transfusion committee. Within Internal Medicine, he directs the differentiation Bloodtransfusion Medicine. Next, Zwaginga is co-responsible for the LUMC-Sanquin Jon J van Rood Center for Clinical Transfusion Medicine Research, chairman of the Benign Hematologic Diseases working party of the Dutch Hematology Association and national ( HOVON ) JACIE representative and chairman of the stearing committee for the Blood transfusion guideline.
More information about Jaap Jan Zwaginga
Within the LUMC Jaap Jan Zwaginga is full professor in Clinical Transfusion Medicine, section leader of the Centre for Stem Cell and Cell therapy both within the department Immunohematology and Bloodtransfusion and chairman of the LUMC Blood transfusion committee. Within Internal Medicine, he directs the differentiation Bloodtransfusion Medicine. Next, Zwaginga is co-responsible for the LUMC-Sanquin Jon J van Rood Center for Clinical Transfusion Medicine Research, chairman of the Benign Hematologic Diseases working party of the Dutch Hematology Association and national ( HOVON ) JACIE representative and chairman of the stearing committee for the Blood transfusion guideline.
Clinical transfusion medicine
Clinical transfusion medicine involves a. the classical use of red blood cells, thrombocytes and plasma, but also b. the “university centre based” immuno-modulatory and regenerative therapies with manipulated blood, marrow or tissue-derived cells.
Classical Blood transfusion research is closely aligned with Sanquin’s (the national blood supply organisation) medical needs. Via the Center for Clinical Transfusion Research (the CCTR) my research focuses on preferentially case-control risk factor and ‘aetiology-hypothesis generating’ studies aided by developing the following: a. A warehouse between Sanquin and UMCUs for clustered datasets on the complete transfusion chain allowing risk factor identifying studies on transfusion related rare events (e.g. alloimmunization, TRALI and severe bleeding), and b. Broad clinical networks enabling (risk factor, biomarker based) personalized transfusion, blood- management and immune-modulatory support. There is a special focus on hemato-oncologic patients with specific transfusion associated side effects like iron overload, patients with allo- or auto-immune cytopenias e.g. ITP, TTP, AIHA, transfusion and pregnancy induced haemolysis.
Advanced cellular therapy research is centred around:
- Enabling the development, production and implementation of ATMP (Advanced Therapy Medicinal - i.e. cellular- Products) for numerous research and patient groups in the LUMC. The most important examples: a. the clinical mesenchymal stromal cell (MSC) program e.g. by biomarker (working- mechanism) comparisons of responding and non-responding patients and, b. stem cell based gene therapy in paediatric patients with severe immune deficiencies.
- The personal program of Zwaginga on (and PI of) tolerogenic DC / immunomodulatory (+MSC) studies in DM-type I and rheumatoid arthritis.
Academic career
Starting his career in the Utrecht University Hospital and later the Amsterdam Medical Center, Prof Zwaginga joined the LUMC department of Immunohematology and Bloodtransfusion in 2005. Being internist- haematologist since 1997 and Blood transfusion specialist since 2008, Zwaginga is active in out-patient care for general hemato-oncologic and immunohematologic patients within the Haematology Department. In the LUMC he additionally is medical consultant, implementer of, and research leader in classical (blood transfusions and hematopoietic stem-cell) medicine as well as in the field of experimental cell therapies.
His University of Utrecht PhD in 1989 dealt with ‘Causes of Uremic Bleeding’ and the title of his Oration in January 2014 was: Links towards Curing Blood.
Professor Clinical Transfusion Medicine
- Faculteit Geneeskunde
- Divisie 4
- Immunologie
- Valk, S.J.; Caram-Deelder, C.; Evers, D.; Vooght, K.M.K. de; Kerkhof, D. van de; Wondergem, M.J.; Péquériaux, N.C.V.; Hudig, F.; Zwaginga, J.J.; Korte, D. de; Watering, L.M.G. van de; Middelburg, R.A. & Bom, J.G. van der (2024), Donor pregnancies and transfusion recipient mortality, Vox Sanguinis 119.
- Levine, A.C.; Fukuta, Y.; Huaman, M.A.; Ou, J.D.; Meisenberg, B.R.; Patel, B.; Paxton, J.H.; Hanley, D.F.; Rijnders, B.J.A.; Gharbharan, A.; Rokx, C.; Zwaginga, J.J.; Alemany, A.; Mitja, O.; Ouchi, D.; Millat-Martinez, P.; Durkalski-Mauldin, V.; Korley, F.K.; Dumont, L.J.; Callaway, C.W.; Libster, R.; Marc, G.P.; Wappner, D.; Esteban, I.; Polack, F. & Sullivan, D.J. (2023), COVID-19 convalescent plasma outpatient therapy to prevent outpatient hospitalization, Clinical Infectious Diseases 76(12): 2077-2086.
- Tonino, R.P.B.; Zwaginga, L.M.; Schipperus, M.R. & Zwaginga, J.J. (2023), Hemoglobin modulation affects physiology and patient reported outcomes in anemic and non-anemic subjects: an umbrella review, Frontiers in Physiology 14.
- Gharbharan, A.; Jordans, C.; Zwaginga, L.; Papageorgiou, G.; Geloven, N. van; Wijngaarden, P. van; Hollander, J. den; Karim, F.; Leeuwen-Segarceanu, E. van; Soetekouw, R.; Lammers, J.; Postma, D.; Kampschreur, L.; Groeneveld, G.; Swaneveld, F.; Schoot, C.E. van der; Gotz, H.; Haagmans, B.; Koopmans, M.; Bogers, S.; Geurtsvankessel, C.; Zwaginga, J.J.; Rokx, C.; Rijnders, B. & CoV-Early study grp (2023), Outpatient convalescent plasma therapy for high-risk patients with early COVID-19, Clinical Microbiology and Infection 29(2): 208-214.
- Vives, J.; Sánchez-Guijo, F.; Gnecchi, M. & Zwaginga, J.J. (2023), Cell and gene therapy workforce development, Cytotherapy 25(10): 1033-1036.
- van Paassen J, Swets MC, Groeneveld GH, de Vries JJC, de Jong Y, ten Brinck RM, Hiemstra PS, Zwaginga JJ, de Jonge E & Arbous MS (2023), Viruses in the respiratory tract in elective cardiac surgery patients , Austin Journal of Pulmonary and Respiratory Medicine 10(1).
- Prakash, A.; Oud, J.; Medved, J.; Arneja, A.; Niebuhr, C.; Zwaginga, J.; Evers, D. & Luckey, C. (2023), CMV Coinfection Enhances RBC Alloimmunization Via a Novel, Type I Interferon-Independent Mechanism, Transfusion 63: 149A-149A.
- Jansen, A.J.G.; Mcdonald, V.; Newland, A.; Morgan, M.; Bastiaanse, M.; Wilson, K.; Eriksson, D.; Geldman, E.; Daykin-Pont, O.; Prince, S. & Zwaginga, J.J. (2023), Patient preferences and experiences regarding thrombopoietin-receptor agonists for immune thrombocytopenia in The Netherlands (TRAPeze Netherlands study), Hematology 28(1).
- Bense, J.E.; Guilonard, N.; Zwaginga, F.; Stiggelbout, A.M.; Louwerens, M.; Mekelenkamp, H.; Lankester, A.C.; Pieterse, A.H. & Pagter, A.P.J. de (2023), The value of using patient-reported outcomes for health screening during long-term follow-up after paediatric stem cell transplantation for nonmalignant diseases, Health Expectations 27(1).
- Bense, J.E.; Guilonard, N.; Zwaginga, F.A.; Stiggelbout, A.M.; Louwerens, M.; Mekelenkamp, H.; Lankester, A.C.; Pieterse, A.H. & Pagter, A.P.J. de (2023), THE VALUE OF USING PATIENT-REPORTED OUTCOMES FOR HEALTH SCREENING DURING LONG-TERM FOLLOW-UP AFTER PEDIATRIC STEM CELL TRANSPLANTATION FOR NONMALIGNANT DISEASES, Bone Marrow Transplantation 58(SUPP1): 132-133.
- Amini, S.N.; Nelson, V.S.; Porcelijn, L.; Netelenbos, T.; Zwaginga, J.J.; Haas, M. de; Schipperus, M.R. & Kapur, R. (2023), The interplay between GPIb/IX antibodies, platelet hepatic sequestration, and TPO levels in patients with chronic ITP, Blood Advances 7(6): 1066-1069.
- Ouboter, L.F.; Barnhoorn, M.C.; Verspaget, H.W.; Plug, L.; Pool, E.S.; Szuhai, K.; Hawinkels, L.J.A.C.; Pel, M. van; Zwaginga, J.J.; Roelen, D.; Koning, F.; Pascutti, M.F. & Meulen-de Jong, A.E. van der (2023), Local administration of mesenchymal stromal cells is safe and modulates the immune compartment in ulcerative proctitis, JCI Insight 8(9).
- Paassen, J. van; Graaf-Dijkstra, A. de; Brunsveld-Reinders, A.H.; Jonge, E. de; Klautz, R.J.M.; Tsonaka, R.; Zwaginga, J.J. & Arbous, M.S. (2023), Leucocyte and platelet activation in cardiac surgery patients with and without lung injury, INTERDISCIPLINARY CARDIOVASCULAR AND THORACIC SURGERY 36(5).
- Halteren, A.G.S. van; Suwandi, J.S.; Tuit, S.; Borst, J.; Laban, S.; Tsonaka, R.; Struijk, A.; Wiekmeijer, A.S.; Pel, M. van; Roep, B.O.; Zwaginga, J.J.; Lankester, A.C.; Schepers, K.; Tol, M.J.D. van & Fibbe, W.E. (2023), A unique immune signature in blood separates therapy-refractory from therapy-responsive acute graft-versus-host disease, Blood 141(11): 1277-1292.
- Tonino, R.; Zwaginga, L.; Schipperus, M.R. & Zwaginga, J.J. (2022), Effect of Change in Haemoglobin Mass on Physiology in Anaemic and Non-Anaemic Subjects: An Umbrella Review, Blood 140: 13138-13140.
- Henricks, L.M.; Huisman, E.J.; Lopriore, E.; Luken, J.S.; Haas, M. de; Ootjers, C.S. & Albersen, A. (2022), Acute haemolytic transfusion reaction after transfusion of fresh frozen plasma in a neonate, Transfusion Medicine.
- Cornelissen, L.L.; Kreuger, A.L.; Caram-Deelder, C.; Huisman, M.V.; Middelburg, R.A.; Kerkhoffs, J.L.H.; Borne, P.A. von dem; Beckers, E.A.M.; Vooght, K.M.K. de; Kuball, J.; Bom, J.G. van der & Zwaginga, J.J. (2022), Association between cardiovascular risk factors and intracranial hemorrhage in patients with acute leukemia, European Journal of Haematology 108(4).
- Amini, S.N.; Porcelijn, L.; Sobels, A.; Kartachova, M.; Haas, M. de; Zwaginga, J.J. & Schipperus, M.R. (2022), Anti-glycoprotein antibodies and sequestration pattern of indium-labeled platelets in immune thrombocytopenia, Blood Advances 6(6): 1797-1803.
- Katiraei, S.; Diepen, J.A. van; Tavares, L.P.; Hoving, L.R.; Pronk, A.; Verschueren, I.; Rensen, P.C.N.; Zwaginga, J.J.; Kostidis, S.; Giera, M.; Teixera, M.; Dijk, K.W. van; Netea, M.G.; Berbee, J.F.P. & Harmelen, V. van (2022), Bone marrow transplantation induces changes in the gut microbiota that chronically increase the cytokine response pattern of splenocytes, Scientific Reports 12(1).
- Tonino, R.P.B.; Schipperus, M.R. & Zwaginga, J.J. (2022), Clinical practice for outpatients that are chronically red cell dependent, Vox Sanguinis 117(4): 526-534.
- Gootjes, C.; Zwaginga, J.J.; Roep, B.O. & Nikolic, T. (2022), Functional impact of risk gene variants on the autoimmune responses in type 1 diabetes, Frontiers in Immunology 13.
- Millat-Martinez, P.; Gharbharan, A.; Alemany, A.; Rokx, C.; Geurtsvankessel, C.; Papageourgiou, G.; Geloven, N. van; Jordans, C.; Groeneveld, G.; Swaneveld, F.; Schoot, E. van der; Corbacho-Monne, M.; Ouchi, D.; Ferreira, F.P.; Malchair, P.; Videla, S.; Garcia, V.G.; Ruiz-Comellas, A.; Ramirez-Morros, A.; Codina, J.R.; Simon, R.A.; Grifols, J.R.; Blanco, J.; Blanco, I.; Ara, J.; Bassat, Q.; Clotet, B.; Baro, B.; Troxel, A.; Zwaginga, J.J.; Mitja, O.; Rijnders, B.J.A.; CoV-Early Study Grp & COnV-ert Study Grp (2022), Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients, Nature Communications 13(1).
- Rijnhout, T.W.H.; Noorman, F.; Horst, R.A. van der; Tan, E.C.T.H.; Viersen, V.V.A.; Waes, O.J.F. van; Watering, L.M.G. van de; Burg, B.L.S.B. van der; Zwaginga, J.J.; Verhofstad, M.H.J. & Hoencamp, R. (2022), The haemostatic effect of deep-frozen platelets versus room temperature-stored platelets in the treatment of surgical bleeding: MAFOD-study protocol for a randomized controlled non-inferiority trial, Trials 23(1).
- Nikolic, T.; Suwandi, J.S.; Wesselius, J.; Laban, S.; Joosten, A.M.; Sonneveld, P.; Mul, D.; Aanstoot, H.J.; Kaddis, J.S.; Zwaginga, J.J. & Roep, B.O. (2022), Tolerogenic dendritic cells pulsed with islet antigen induce long-term reduction in T-cell autoreactivity in type 1 diabetes patients, Frontiers in Immunology 13.
- Oud, J.A.; Evers, D.; Haas, M. de; Vooght, K.M.K. de; Kerkhof, D. van de; Som, N.; Pequeriaux, N.C.V.; Hudig, F.; Bom, J.G. van der & Zwaginga, J.J. (2022), Transfusion-induced red blood cell alloimmunisation is unhampered in elderly patients.
- Cornelissen, L.L.; Caram-Deelder, C.; Fustolo-Gunnink, S.F.; Groenwold, R.H.H.; Stanworth, S.J.; Zwaginga, J.J. & Bom, J.G. van der (2021), Expected individual benefit of prophylactic platelet transfusions in hemato-oncology patients based on bleeding risks, Transfusion 61(9): 2578-2587.
- Wojcik, I.; Schmidt, D.E.; Neef, L.A. de; Rab, M.A.E.; Meek, B.; Weerdt, O. de; Wuhrer, M.; Schoot, C.E. van der; Zwaginga, J.J.; Haas, M. de; Falck, D. & Vidarsson, G. (2021), A functional spleen contributes to afucosylated IgG in humans, Scientific Reports 11(1).
- Khatri, I.; Diks, A.M.; Akker, E.B. van den; Oosten, L.E.M.; Zwaginga, J.J.; Reinders, M.J.T.; Dongen, J.J.M. van & Berkowska, M.A. (2021), Longitudinal dynamics of human B-cell response at the single-cell level in response to Tdap vaccination, Vaccines 9(11).
- Drs, L.O.; Barnhoorn, M.; Pel, M. van; Zwaginga, J.J.; Hawinkels, L.; Maljaars, J.; Koning, F.; Verspaget, H. & Meulen-de de Jong, A. van der (2021), Locally injected allogeneic bone marrow-derived mesenchymal stromal cells for the treatment of refractory proctitis: clinical results of a phase IIa trial, Journal of Crohn's and Colitis 15: S381-S381.
- Ouboter, L.; Barnhoorn, M.; Plug, L.; Pel, M. van; Zwaginga, J.J.; Roelen, D.; Pascutti, E.; Koning, F.; Hawinkels, L.; Verspaget, H. & Meulen-de Jong, A. van der (2021), Endoscopically injected allogeneic mesenchymal stromal cells alter the mucosal immune cell compartment in patients with ulcerative proctitis, Journal of Crohn's and Colitis 15: S098-S099.
- Nelson, V.S.; Jolink, A.T.C.; Amini, S.N.; Zwaginga, J.J.; Netelenbos, T.; Semple, J.W.; Porcelijn, L.; Haas, M. de; Schipperus, M.R. & Kapur, R. (2021), Platelets in ITP: victims in charge of their own fate?, Cells 10(11).
- Nelson, V.S.; Jolink, A.T.C.; Amini, S.N.; Zwaginga, J.J.; Netelenbos, T.; Semple, J.W.; Porcelijn, L.; Haas, M. de; Schipperus, M.R. & Kapur, R. (2021), Platelets in ITP: Victims in Charge of Their Own Fate?, Cells.
- Tonino, R.P.B.; Wilson, M.; Zwaginga, J.J. & Schipperus, M.R. (2021), Prevalence of iron deficiency and red blood cell transfusions in surgical patients, Vox Sanguinis 117(3).
- Luken, J.S.; Folman, C.C.; Lukens, M.V.; Meekers, J.H.; Ligthart, P.C.; Schonewille, H.; Zwaginga, J.J.; Janssen, M.P.; Schoot, C.E. van der; Bom, J.G. van der & Haas, M. de (2021), Reduction of anti-K-mediated hemolytic disease of newborns after the introduction of a matched transfusion policy, Transfusion 61(3).
- Oud, J.A.; Evers, D.; Middelburg, R.A.; Vooght, K.M.K. de; Kerkhof, D. van de; Visser, O.; Pequeriaux, N.C.V.; Hudig, F.; Bom, J.G. van der & Zwaginga, J.J. (2021), Association between renal failure and red blood cell alloimmunization among newly transfused patients, Transfusion 61(1): 35-41.
- Amini, S.N.; Nelson, V.S.; Sobels, A.; Schoones, J.W.; Zwaginga, J.J. & Schipperus, M.R. (2020), Autologous platelet scintigraphy and clinical outcome of splenectomy in immune thrombocytopenia, Critical Reviews in Oncology/Hematology 153.
- Schmidt, D.E.; Haan, N. de; Sonneveld, M.E.; Porcelijn, L.; Schoot, C.E. van der; Haas, M. de; Zwaginga, J.J.; Wuhrer, M. & Vidarsson, G. (2020), IgG-Fc glycosylation before and after rituximab treatment in immune thrombocytopenia, Scientific Reports 10(1).
- Nikolic, T.; Zwaginga, J.J.; Uitbeijerse, B.S.; Woittiez, N.J.; Koning, E.J. de; Aanstoot, H.J. & Roep, B.O. (2020), Safety and feasibility of intradermal injection with tolerogenic dendritic cells pulsed with proinsulin peptide-for type 1 diabetes.
- Cornelissen, L.L.; Caram-Deelder, C.; Meier, R.T.; Zwaginga, J.J.; Evers, D. & Dutch Blood Transfusion Related R (2020), Platelet transfusion and tranexamic acid to prevent bleeding in outpatients with a hematological disease, European Journal of Haematology 106(3).
- Lopriore, E.; Huisman, E.; Zwaginga, J.J.; Snijder, P.M.; Reiss, I.K. & Stanworth, S. (2020), Allogeneic cord blood transfusions for extremely preterm neonates: an extremely promising proof of concept, British Journal of Haematology 191(2): 150-151.
- Achini, F.R.; Smiers, F.; Zwaginga, J.J.; Tol, M.J.D. van; Jol-van der Zijde, C.M.; Schilham, M.W.; Lankester, A.C. & Bredius, R.G.M. (2020), Plasmapheresis to eliminate immunosuppressive alemtuzumab levels in a child with disseminated adenovirus infection after allogeneic stem cell transplantation.
- Drs, L.O.; Barnhoorn, M.C.; Hawinkels, L.J.A.C.; Pel, M. van; Zwaginga, J.J.; Verspaget, H.W.; Koning, F.; Pascutti, M.F. & Meulen-de Jong, A.E. van der (2020), High-dimensional mass cytometry after local MSC treatment in patients with refractory proctitis shows an effect on the myeloid compartment: preliminary data, Journal of Crohn's and Colitis 14: S174-S175.
- Henriquez, D.D.C.A.; Bloemenkamp, K.W.M.; Loeff, R.M.; Zwart, J.J.; Roosmalen, J.J.M. van; Zwaginga, J.J.; Bom, J.G. van der; Adriaanse, H.J.; Akker, E.S.A. van den; Baas, M.I.; Bank, C.M.C.; Beek, E. van; Boer, B.A. de; Boer, K. de; Borden, D.M.R. van der; Bremer, H.A.; Brons, J.T.J.; Burggraaff, J.M.; Ceelie, H.; Chon, H.; Cikot, J.L.M.; Delemarre, F.M.C.; Diris, J.H.C.; Doesburg-van Kleffens, M.; Dooren, I.M.A. van; Duijnhoven, J.L.P. van; Dunne, F.M. van; Duvekot, J.J.; Engbers, P.; Hulst, M.J.W.V.; Feitsma, H.; Fouraux, M.A.; Franssen, M.T.M.; Frasa, M.A.M.; Gammeren, A.J. van; Gemund, N. van; Graaf, F. van der; Groot, C.J.M. de; Hackeng, C.M.; Ham, D.P. van der; Hanssen, M.J.C.P.; Hasaart, T.H.M.; Hendriks, H.A.; Henskens, Y.M.C.; Hermsen, B.B.J.; Hogenboom, S.; Hooker, A.; Hudig, F.; Huijssoon, A.M.G.; Huisjes, A.J.M.; Jonker, N.; Kabel, P.J.; Kampen, C. van; Keijzer, M.H. de; Kerkhof, D.H. van de; Keuren, J.F.W.; Kleiverda, G.; Klinkspoor, J.H.; Koehorst, S.G.A.; Kok, M.; Kok, R.D.; Kok, J.B. de; Koops, A.; Kortlandt, W.; Langenveld, J.; Leers, M.P.G.; Leyte, A.; Mare, A. de; Martens, G.D.M.; Meekers, J.H.; Meir, C.A. van; Metz, G.C.H.; Michielse, E.C.H.J.; Mostert, L.J.; Bijvank, S.W.H.N.; Oostenveld, E.; Osmanovic, N.; Oudijk, M.A.; Mirani-Oostdijk, C.P.; Pampus, E.C.M. van; Papatsonis, D.N.M.; Peters, R.H.M.; Ponjee, G.A.E.; Pontesilli, M.; Porath, M.M.; Post, M.S.; Pouwels, J.G.J.; Prinzen, L.; Roelofsen, J.M.T.; Rondeel, J.J.M.; Salm, P.C.M. van der; Scheepers, H.C.J.; Schippers, D.H.; Schuitemaker, N.W.E.; Sikkema, J.M.; Slomp, J.; Smit, J.W.; Snuif-de Lange, Y.S.; Stappen, J.W.J. van der; Steures, P.; Tax, G.H.M.; Treskes, M.; Ulenkate, H.J.L.M.; Unnik, G.A. van; Veen, B.S. van der; Verhagen, T.E.M.; Versendaal, J.; Visschers, B.; Visser, O.; Visser, H.; Vooght, K.M.K. de; Vries, M.J. de; Waard, H. de; Weerkamp, F.; Weinans, M.J.N.; Wet, H. de; Wijnen, M. van; Wijngaarden, W.J. van; Wit, A.C. de; Woiski, M.D. & TeMpOH-Study Grp (2019), Fluid resuscitation during persistent postpartum haemorrhage and maternal outcome: A nationwide cohort study, European Journal of Obstetrics and Gynecology and Reproductive Biology 235: 49-56.
- Counsilman, C.E.; Heeger, L.E.; Tan, R.; Bekker, V.; Zwaginga, J.J.; Pas, A.B. te & Lopriore, E. (2019), Iatrogenic blood loss in extreme preterm infants due to frequent laboratory tests and procedures, Journal of Maternal-Fetal and Neonatal Medicine.
- Mann, I.; Tseng, C.C.S.; Rodrigo, S.F.; Koudstaal, S.; Ramshorst, J. van; Beeres, S.L.; Dibbets-Schneider, P.; Geus-Oei, L.F. de; Lamb, H.J.; Wolterbeek, R.; Zwaginga, J.J.; Fibbe, W.E.; Westinga, K.; Bax, J.J.; Doevendans, P.A.; Schalij, M.J.; Chamuleau, S.A.J. & Atsma, D.E. (2019), Intramyocardial bone marrow cell injection does not lead to functional improvement in patients with chronic ischaemic heart failure without considerable ischaemia, Netherlands Heart Journal 27(2): 81-92.
- Ypma, P.F.; Geloven, N. van; Kerkhoffs, J.L.H.; Boekhorst, P. te; Zwaginga, J.J.; Beckers, E.A.M.; Brand, A.; Meer, P.F. van der & Eikenboom, J.C.J. (2019), The association between haemorrhage and markers of endothelial insufficiency and inflammation in patients with hypoproliferative thrombocytopenia: a cohort study, British Journal of Haematology.
- Hezel, M.E. van; Manen, L. van; Boshuizen, M.; Straat, M.; Cuyper, I.M. de; Beuger, B.; Nieuwland, R.; Tanck, M.W.T.; Korte, D. de; Zwaginga, J.J.; Bruggen, R. van & Juffermans, N.P. (2019), The effect of red blood cell transfusion on platelet function in critically ill patients, Thrombosis Research 184: 115-121.
- Saris, A.; Kreuger, A.L.; Brinke, A. ten; Kerkhoffs, J.L.H.; Middelburg, R.A.; Zwaginga, J.J. & Meer, P.F. van der (2019), The quality of platelet concentrates related to corrected count increment: linking in vitro to in vivo, Transfusion 59(2): 697-706.
- Saris, A.; Kerkhoffs, J.L.; Norris, P.J.; Ham, S.M. van; Brinke, A. ten; Brand, A.; Meer, P.F. van der & Zwaginga, J.J. (2019), The role of pathogen-reduced platelet transfusions on HLA alloimmunization in hemato-oncological patients, Transfusion 59(2): 470-481.
- Ramler, P.I.; Henriquez, D.D.C.A.; Akker, T. van den; Caram-Deelder, C.; Groenwold, R.H.H.; Bloemenkamp, K.W.M.; Roosmalen, J. van; Lith, J.M.M. van; Bom, J.G. van der; Cessie, S.; Eikenboom, H.C.J.; So-Osman, C.; Watering, L.M.G. van de; Zwaginga, J.J.; Zwart, J.J.; Loeff, R.M.; Goeverden, R.J. van; Eijlers, B.; Hillebrand, A.; Spelmin, S.E.; Beunder, T.J.; Harskamp, V.; Wind, M.; Koning, M.D.; Cramer, R.A.; Veenstra, A.; Smith, S.M.; Ensing, E.E.; Brussel-de Groot, C.J. van; Zouitni, O. & TeMpOH-1 Study Grp (2019), Comparison of outcome between intrauterine balloon tamponade and uterine artery embolization in the management of persistent postpartum hemorrhage: A propensity score-matched cohort study, Acta Obstetricia et Gynecologica Scandinavica 98(11): 1473-1482.
- Paassen, J.; Dissel, J.T. van; Hiemstra, P.S.; Zwaginga, J.J.; Cobbaert, C.M.; Juffermans, N.P.; Wilde, R.B. de; Stijnen, T.; Jonge, E. de; Klautz, R.J. & Arbous, M.S. (2019), Perioperative proADM-change is associated with the development of acute respiratory distress syndrome in critically ill cardiac surgery patients: a prospective cohort study, Biomarkers in Medicine 13(13): 1081-1091.
- Heeger, L.E.; Counsilman, C.E.; Bekker, V.; Bergman, K.A.; Zwaginga, J.J.; Pas, A.B. te & Lopriore, E. (2019), Restrictive guideline for red blood cell transfusions in preterm neonates: effect of a protocol change, Vox Sanguinis 114(1): 57-62.
- Netelenbos, T.; Massey, E.; Wreede, L.C. de; Harding, K.; Hamblin, A.; Sekhar, M.; Li, A.; Ypma, P.F.; Ball, L.; Zwaginga, J.J. & Stanworth, S.J. (2019), The burden of invasive infections in neutropenic patients: incidence, outcomes, and use of granulocyte transfusions, Transfusion 59(1): 160-168.
- Meer, P.F. van der; Ypma, P.F.; Geloven, N. van; Hilten, J.A. van; Wordragen-Vlaswinkel, R.J. van; Eissen, O.; Zwaginga, J.J.; Trus, M.; Beckers, E.A.M.; Boekhorst, P. te; Tinmouth, A.; Lin, Y.L.; Hsia, C.; Lee, D.; Norris, P.J.; Goodrich, R.P.; Brand, A.; Hervig, T.; Heddle, N.M.; Bom, J.G. van der & Kerkhoffs, J.L.H. (2018), Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial, Blood 132(2): 223-231.
- Kreuger, A.L.; Middelburg, R.A.; Beckers, E.A.M.; Vooght, K.M.K. de; Zwaginga, J.J.; Kerkhoffs, J.L.H. & Bom, J.G. van der (2018), The identification of cases of major hemorrhage during hospitalization in patients with acute leukemia using routinely recorded healthcare data, PLoS ONE 13(8).
- Overdevest, J.; Lankester, A.; Borne, P.V.; Zwaginga, J.J. & Netelenbos, T. (2018), High volume and erythrocyte content of umbilical cord blood units predict risk of poor engraftment, Bone Marrow Transplantation 53: 499-499.
- Bosboom, J.J.; Klanderman, R.B.; Peters, A.L.; Weerdt, E.K. van de; Goudswaard, E.J.; Binnekade, J.M.; Zwaginga, J.J.; Beckers, E.A.M.; Geerts, B.F.; Hollmann, M.W.; Zeerleder, S.S.; Kraaij, M. van & Vlaar, A.P. (2018), The practice of diagnosing and reporting transfusion-associated circulatory overload: a national survey among physicians and haemovigilance officers, Transfusion Medicine 28(5): 363-370.
- Jedema, I.; Balen, P. van; Halkes, C.J.M.; Egmond, E.H.M. van; Liempt, E.A.G. van; Veld, S.A.J.; Hoogstraten, C.; Meij, P.; Kersting, S.; Zwaginga, J.J.; Rauser, G.; Assenmacher, M. & Falkenburg, J.H.F. (2018), Phase I/II clinical trial demonstrates feasibility, safety and effectivity of CMV-pp65-specific donor T-cells for the treatment of refractory CMV reactivation after allogeneic stem cell transplantation, Bone Marrow Transplantation 53: 45-45.
- Roex, M.C.J.; Balen, P. van; Germeroth, L.; Hageman, L.; Egmond, E. van; Veld, S.A.J.; Hoogstraten, C.; Liempt, E. van; Zwaginga, J.J.; Wreede, L.C. de; Einsele, H.; Veelken, H.; Halkes, C.J.M.; Jedema, I. & Falkenburg, J.H.F. (2018), Prophylactic Infusion of Multi-Antigen Specific T-Cell Products to Prevent Complications after T Cell Depleted Allogeneic Stem Cell Transplantation - a Phase I/II Study, Blood 132.
- Winkelhorst D., Oostweegel M., Porcelijn L., Middelburg R., Zwaginga J-J, Oepkes D., van der Bom J. G., de Haas M., Lopriore E. & Zwiers C. (2018), Treatment and outcomes of fetal/neonatal alloimmune thrombocytopenia: A nationwide cohort study in newly detected cases, BJOG: An International Journal of Obstetrics and Gynaecology 125: 97-97.
- Overdevest, J.; Spruitenburg, P.; Zwaginga, J.J. & Netelenbos, T. (2018), Understanding collection efficiency and recovery in stimulated and non-stimulated blood- and bone marrow apheresis, Bone Marrow Transplantation 53: 790-791.
- Muijsenberg, J. van den; Overdevest, J.; Marvelde, P. te; Rozier, Y.; Zwaginga, J.J. & Netelenbos, T. (2018), Viability of CD34-selected cells in vials, a poor quality predictor for cryopreserved CD34-enriched stem cell transplants, Bone Marrow Transplantation 53: 791-792.
- Hoeks, M.; Pol, M. van der; Middelburg, R.; Evers, D.; Kraaij, M. van & Zwaginga, J.J. (2018), Bone marrow iron score as an indicator for secondary iron overload in acute myeloid leukemia patients, European Journal of Haematology 101(5): 591-594.
- Balen, P. van; Bergen, C.A.M. van; Luxemburg-Heijs, S.A.P. van; Klerk, W. de; Egmond, E.H.M. van; Veld, S.A.J.; Halkes, C.J.M.; Zwaginga, J.J.; Griffioen, M.; Jedema, I. & Falkenburg, J.H.F. (2018), CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II, Frontiers in Immunology 9.
- Porcelijn, L.; Huiskes, E.; Oldert, G.; Schipperus, M.; Zwaginga, J.J. & Haas, M. de (2018), Detection of platelet autoantibodies to identify immune thrombocytopenia: state of the art, British Journal of Haematology 182(3): 423-426.
- Saris, A.; Peyron, I.; Meer, P.F. van der; Stuge, T.B.; Zwaginga, J.J.; Ham, S.M. van & Brinke, A. ten (2018), Storage-Induced Platelet Apoptosis Is a Potential Risk Factor for Alloimmunization Upon Platelet Transfusion, Frontiers in Immunology 9.
- Lindeman, J.H.N.; Zwaginga, J.J.; Kallenberg-Lantrua, G.; Wissen, R.C. van; Schepers, A.; Bockel, H.J. van; Fibbe, W.E. & Hamming, J.F. (2018), No Clinical Benefit of Intramuscular Delivery of Bone Marrow-derived Mononuclear Cells in Nonreconstructable Peripheral Arterial Disease Results of a Phase-III Randomized-controlled Trial, Annals of Surgery 268(5): 756-761.
- Wilson, M.J.; Koopman-van Gemert, A.W.M.M.; Harlaar, J.J.; Jeekel, J.; Zwaginga, J.J. & Schipperus, M. (2018), Patient blood management in colorectal cancer patients: a survey among Dutch gastroenterologists, surgeons, and anesthesiologists, Transfusion 58(10): 2345-2351.
- Wilson, M.J.; Harlaar, J.J.; Jeekel, J.; Schipperus, M. & Zwaginga, J.J. (2018), Iron therapy as treatment of anemia: A potentially detrimental and hazardous strategy in colorectal cancer patients, Medical Hypotheses 110: 110-113.
- Hoeks, M.P.A.; Middelburg, R.A.; Romeijn, B.; Blijlevens, N.M.A.; Kraaij, M.G.J. van & Zwaginga, J.J. (2018), Red blood cell transfusion support and management of secondary iron overload in patients with haematological malignancies in the Netherlands: a survey, Vox Sanguinis 113(2): 152-159.
- Peters, A.L.; Weerdt, E.K. van de; Goudswaard, E.J.; Binnekade, J.M.; Zwaginga, J.J.; Beckers, E.A.M.; Zeerleder, S.S.; Kraaij, M.G.J. van; Juffermans, N.P. & Vlaar, A.P.J. (2018), Reporting transfusion-related acute lung injury by clinical and preclinical disciplines, Blood Transfusion == 16(3): 227-234.
- Kruizinga, M.D.; Tol, M.J.D. van; Bekker, V.; Netelenbos, T.; Smiers, F.J.; Bresters, D.; Jansen-Hoogendijk, A.M.; Ostaijen-ten Dam, M.M. van; Kollen, W.J.W.; Zwaginga, J.J.; Lankester, A.C. & Bredius, R.G.M. (2018), Risk Factors, Treatment, and Immune Dysregulation in Autoimmune Cytopenia after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients, Biology of Blood and Marrow Transplantation 24(4): 772-778.
- Thielen, F.W.; Blommestein, H.M.; Oosten, L.E.M.; Calkoen, F.G.; Lankester, A.C.; Zwaginga, J.J.; Blanc, K. le; Redondo, A.; Sanchez-Guijo, F.; Algeri, M.; Locatelli, F.; Fibbe, W.E. & Uyl-de Groot, C.A. (2018), Second-line treatment for acute graft-versus-host disease with mesenchymal stromal cells: A decision model, European Journal of Haematology 101(5): 676-683.
- Wilson, M.J.; Dekker, J.W.; Bruns, E.; Borstlap, W.; Jeekel, J.; Zwaginga, J.J. & Schipperus, M. (2018), Short-term effect of preoperative intravenous iron therapy in colorectal cancer patients with anemia: results of a cohort study, Transfusion 58(3): 795-803.
- Wilson, M.J.; Dekker, J.W.T.; Buettner, S.; Harlaar, J.J.; Jeekel, J.; Schipperus, M. & Zwaginga, J.J. (2018), The effect of intravenous iron therapy on long-term survival in anaemic colorectal cancer patients: Results from a matched cohort study, Surgical Oncology 27(2): 192-199.
- Wilson M., Dekker J., Buettner S., Verhoef C., Harlaar J., Jeekel J., Schipperus M. & Zwaginga J. (2018), The Effect of Intravenous Iron Therapy on Long-Term Survival in Anemic Colorectal Cancer Patients: Results From a Matched Cohort Study, Annals of Surgical Oncology 25: S154-S154.
- Caram-Deelder, C.; Bom, J.G. van der; Putter, H.; Leyte, A.; Kerkhof, D. van de; Evers, D.; Beckers, E.A.; Weerkamp, F.; Hudig, F.; Zwaginga, J.J.; Rondeel, J.M.M.; Vooght, K.M.K. de; Pequeriaux, N.C.V.; Visser, O.; Wallis, J.P. & Middelburg, R.A. (2018), Age of platelet concentrates and time to the next transfusion, Transfusion 58(1): 121-131.
- Zeller, M.P.; Barty, R.; Dunbar, N.M.; Elahie, A.; Flanagan, P.; Garritsen, H.; Kutner, J.M.; Pagano, M.B.; Poglod, R.; Rogers, T.S.; Staves, J.; Wordragen-Vlaswinkel, M. van; Zwaginga, J.J.; Murphy, M.F.; Heddle, N.M.; Yazer, M.H. & Biomed Excellence Safer (2018), An international investigation into AB plasma administration in hospitals: how many AB plasma units were infused? The HABSWIN study, Transfusion 58(1): 151-157.
- Saris, A.; Tomson, B.; Brand, A.; Mulder, A.; Claas, F.H.; Lorinser, J.; Scharenberg, J.; Ham, S.M. van; Brinke, A. ten; Zwaginga, J.J. & Meer, P.F. van der (2018), Platelets from donors with consistently low HLA-B8,-B12, or-B35 expression do not undergo antibody-mediated internalization, Blood 131(1): 144-152.
- Kruizinga, M.; Tol, M. van; Bekker, V.; Smiers, F.; Bresters, D.; Bakker-Steeneveld, H.; Jansen-Hoogendijk, A.; Kollen, W.; Zwaginga, J.J.; Lankester, A. & Bredius, R. (2017), Autoimmune cytopenia following allogeneic hematopoietic stem cell transplantation in pediatric patients, Bone Marrow Transplantation 52: S350-S351.
- Yazer, M.H.; Watering, L. van de; Lozano, M.; Sirdesai, S.; Rushford, K.; Wood, E.M.; Yokoyama, A.P.; Kutner, J.M.; Lin, Y.; Callum, J.; Cserti-Gazdewich, C.; Lieberman, L.; Pendergrast, J.; Pendry, K.; Murphy, M.F.; Selleng, K.; Greinacher, A.; Marwaha, N.; Sharma, R.; Jain, A.; Orlin, Y.; Yahalom, V.; Perseghin, P.; Incontri, A.; Masera, N.; Okazaki, H.; Ikeda, T.; Nagura, Y.; Zwaginga, J.J.; Poglod, R.; Rosiek, A.; Letowska, M.; Yuen, J.; Cid, J.; Harm, S.K. & Adhikari, P. (2017), Development of RBC transfusion indications and the collection of patient-specific pre-transfusion information: summary, Vox Sanguinis 112(5): 487-494.
- Nikolic, T.; Woittiez, N.J.C.; Slik, A. van der; Laban, S.; Joosten, A.; Gysemans, C.; Mathieu, C.; Zwaginga, J.J.; Koeleman, B. & Roep, B.O. (2017), Differential transcriptome of tolerogenic versus inflammatory dendritic cells points to modulated T1D genetic risk and enriched immune regulation, Genes and Immunity 18(3): 176-183.
- Vicente-Ayuso, C.; Papadopoulos, P.; Villa-Fajardo, M.; Prieto, B.; Alvarez-Carmona, A.M.; Mateo-Morales, M.; Perez-Lopez, C.; Pena-Cortijo, A.; Polo-Zarzuela, M.; Saez, I.; Martin, M.P.; Benavente-Cuesta, C.; Gonzalez-Fernandez, A.; Martinez-Martinez, R.; Zwaginga, J.J.; Seghatchian, J. & Gutierrez, L. (2017), Identification of underlying and transfusion-related platelet qualitative alterations in the hemato-oncologic patient, Transfusion and Apheresis Science 56(5): 756-768.
- Hoeks, M.P.A.; Kranenburg, F.J.; Middelburg, R.A.; Kraaij, M.G.J. van & Zwaginga, J.J. (2017), Impact of red blood cell transfusion strategies in haemato-oncological patients: a systematic review and meta-analysis, British Journal of Haematology 178(1): 137-151.
- Caram-Deelder, C.; Kreuger, A.L.; Evers, D.; Vooght, K.M.K. de; Kerkhof, D.V. de; Visser, O.; Pequeriaux, N.C.V.; Hudig, F.; Zwaginga, J.J.; Bom, J.G. van der & Middelburg, R.A. (2017), Association of Blood Transfusion From Female Donors With and Without a History of Pregnancy With Mortality Among Male and Female Transfusion Recipients, Journal of the American Medical Association 318(15): 1471-1478.
- Porcelijn, L.; Huiskes, E.; Schipperus, M.; Holt, B. van der; Haas, M. de; Zwaginga, J.J. & Dutch HOVON 64 Study Grp (2017), Lack of detectable platelet autoantibodies is correlated with nonresponsiveness to rituximab treatment in ITP patients, Blood 129(25): 3389-3391.
- Wilson, M.J.; Dekker, J.W.T.; Harlaar, J.J.; Jeekel, J.; Schipperus, M. & Zwaginga, J.J. (2017), The role of preoperative iron deficiency in colorectal cancer patients: prevalence and treatment, International Journal of Colorectal Disease 32(11): 1617-1624.
- Yazer, M.H.; Watering, L. van de; Lozano, M.; Sirdesai, S.; Rushford, K.; Wood, E.M.; Yokoyama, A.P.; Kutner, J.M.; Lin, Y.; Callum, J.; Cserti-Gazdewich, C.; Lieberman, L.; Pendergrast, J.; Pendry, K.; Murphy, M.F.; Selleng, K.; Greinacher, A.; Marwaha, N.; Sharma, R.; Jain, A.; Orlin, Y.; Yahalom, V.; Perseghin, P.; Incontri, A.; Masera, N.; Okazaki, H.; Ikeda, T.; Nagura, Y.; Zwaginga, J.J.; Poglod, R.; Rosiek, A.; Letowska, M.; Yuen, J.; Cid, J.; Harm, S.K. & Adhikari, P. (2017), Development of RBC transfusion indications and the collection of patient-specific pre-transfusion information, Vox Sanguinis 112(5): E22-E47.
- Wilson, M.J.; Haaren, M. van; Harlaar, J.J.; Park, H.C.; Bonjer, H.J.; Jeekel, J.; Zwaginga, J.J. & Schipperus, M. (2017), Long-term prognostic value of preoperative anemia in patients with colorectal cancer: A systematic review and meta-analysis, Surgical Oncology 26(1): 96-104.
- Zeller, M.P.; Barty, R.; Aandahl, A.; Apelseth, T.O.; Callum, J.; Dunbar, N.M.; Elahie, A.; Garritsen, H.; Hancock, H.; Kutner, J.M.; Manukian, B.; Mizuta, S.; Okuda, M.; Pagano, M.B.; Poglod, R.; Rushford, K.; Selleng, K.; Sorensen, C.H.; Sprogoe, U.; Staves, J.; Weiland, T.; Wendel, S.; Wood, E.M.; Watering, L. van de; Wordragen-Vlaswinkel, M. van; Ziman, A.; Zwaginga, J.J.; Murphy, M.F.; Heddle, N.M.; Yazer, M.H. & Biomed Excellence Safer (2017), An international investigation into O red blood cell unit administration in hospitals: the GRoup O Utilization Patterns (GROUP) study, Transfusion 57(10): 2329-2337.
- Kreuger, A.L.; Middelburg, R.A.; Bank, C.M.C.; Beckers, E.A.M.; Gammeren, A.J. van; Leyte, A.; Rondeel, J.M.M.; Vooght, K.M.K. de; Weerkamp, F.; Zwaginga, J.J.; Kerkhoffs, J.L.H. & Bom, J.G. van der (2017), Storage time of platelet concentrates and all-cause bacteremia in hematologic patients, Transfusion 57(9): 2096-2103.
- Wilson, M.J.; Haaren, M. van; Harlaar, J.J.; Park, H.C.; Bonjer, H.J.; Jeekel, J.; Zwaginga, J.J. & Schipperus, M. (2017), Long-term prognostic value of preoperative anemia in patients with colorectal cancer: A systematic review and meta-analysis, Surgical Oncology 26(1): 96-104.
- Oostrum, A. van; Zwaginga, J.J.; Croockewit, S.; Overdevest, J.; Fechter, M.; Ruiterkamp, B.; Brand, A. & Netelenbos, T. (2017), Predictors for successful PBSC collection on the fourth day of G-CSF-induced mobilization in allogeneic stem cell donors, Journal of Clinical Apheresis 32(6): 397-404.
- Rodrigo, S.F.; Mann, I.; Ramshorst, J. van; Beeres, S.L.; Zwaginga, J.J.; Fibbe, W.E.; Bax, J.J.; Schalij, M.J. & Atsma, D.E. (2017), Safety and efficacy of percutaneous intramyocardial bone marrow cell injection for chronic myocardial ischemia: Long-term results, Journal of Interventional Cardiology 30(5): 440-447.
- Evers, D.; Bom, J.G. van der; Tijmensen, J.; Haas, M. de; Middelburg, R.A.; Vooght, K.M.K. de; Kerkhof, D.V. van de; Visser, O.; Pequeriaux, N.C.V.; Hudig, F. & Zwaginga, J.J. (2017), Absence of the spleen and the occurrence of primary red cell alloimmunization in humans, Haematologica 102(8): E289-E292.
- Winkelhorst, D.; Kamphuis, M.M.; Kloet, L.C. de; Zwaginga, J.J.; Oepkes, D. & Lopriore, E. (2016), Severe bleeding complications other than intracranial hemorrhage in neonatal alloimmune thrombocytopenia: a case series and review of the literature., Transfusion 56(5).
- Rodrigo, S.F.; Mann, I.; Rarnshorst, J. van; Beeres, S.L.M.A.; Zwaginga, J.J.; Fibbe, W.E.; Bax, J.J.; Schalij, M.J. & Atsma, D.E. (2016), Reduction of healthcare utilization after bone marrow cell therapy for refractory angina pectoris, International Journal of Cardiology 202: 571-572.
- Winkelhorst, D.; Kamphuis, M.M.; Kloet, L.C. de; Zwaginga, J.J.; Oepkes, D. & Lopriore, E. (2016), Severe bleeding complications other than intracranial hemorrhage in neonatal alloimmune thrombocytopenia: a case series and review of the literature, Transfusion 56(5): 1230-1235.
- Evers, D.; Middelburg, R.A.; Haas, M. de; Zalpuri, S.; Vooght, K.M.K. de; Kerkhof, D. van de; Visser, O.; Pequeriaux, N.C.; Hudig, F.; Schonewille, H.; Zwaginga, J.J. & Bom, J.G. van der (2016), Red-blood-cell alloimmunisation in relation to antigens' exposure and their immunogenicity: a cohort study, Lancet Haematology 3(6): E284-E292.
- Engert, A.; Balduini, C.; Brand, A.; Coiffier, B.; Cordonnier, C.; Dohner, H.; Wit, T.D. de; Eichinger, S.; Fibbe, W.; Green, T.; Haas, F. de; Iolascon, A.; Jaffredo, T.; Rodeghiero, F.; Salles, G.; Schuringa, J.J.; Andre, M.; Andre-Schmutz, I.; Bacigalupo, A.; Bochud, P.Y.; Boer, M. den; Bonini, C.; Camaschella, C.; Cant, A.; Cappellini, M.D.; Cazzola, M.; Celso, C. lo; Dimopoulos, M.; Douay, L.; Dzierzak, E.; Einsele, H.; Ferreri, A.; Franceschi, L. de; Gaulard, P.; Gottgens, B.; Greinacher, A.; Gresele, P.; Gribben, J.; Haan, G. de; Hansen, J.B.; Hochhaus, A.; Kadir, R.; Kaveri, S.; Kouskoff, V.; Kuhne, T.; Kyrle, P.; Ljungman, P.; Maschmeyer, G.; Mendez-Ferrer, S.; Milsom, M.; Mummery, C.; Ossenkoppele, G.; Pecci, A.; Peyvandi, F.; Philipsen, S.; Reitsma, P.; Ribera, J.M.; Risitano, A.; Rivella, S.; Ruf, W.; Schroeder, T.; Scully, M.; Socie, G.; Staal, F.; Stanworth, S.; Stauder, R.; Stilgenbauer, S.; Tamary, H.; Theilgaard-Monch, K.; Thein, S.L.; Tilly, H.; Trneny, M.; Vainchenker, W.; Vannucchi, A.M.; Viscoli, C.; Vrielink, H.; Zaaijer, H.; Zanella, A.; Zolla, L.; Zwaginga, J.J.; Martinez, P.A.; Akker, E. van den; Allard, S.; Anagnou, N.; Andolfo, I.; Andrau, J.C.; Angelucci, E.; Anstee, D.; Aurer, I.; Avet-Loiseau, H.; Aydinok, Y.; Bakchoul, T.; Balduini, A.; Barcellini, W.; Baruch, D.; Baruchel, A.; Bayry, J.; Bento, C.; Berg, A. van den; Bernardi, R.; Bianchi, P.; Bigas, A.; Biondi, A.; Bohonek, M.; Bonnet, D.; Borchmann, P.; Borregaard, N.; Braekkan, S.; Brink, M. van den; Brodin, E.; Bullinger, L.; Buske, C.; Butzeck, B.; Cammenga, J.; Campo, E.; Carbone, A.; Cervantes, F.; Cesaro, S.; Charbord, P.; Claas, F.; Cohen, H.; Conard, J.; Coppo, P.; Corrons, J.L.V.; Costa, L. da; Davi, F.; Delwel, R.; Dianzani, I.; Domanovic, D.; Donnelly, P.; Drnovsek, T.D.; Dreyling, M.; , M.Q. du; Dufour, C.; Durand, C.; Efremov, D.; Eleftheriou, A.; Elion, J.; Emonts, M.; Engelhardt, M.; Ezine, S.; Falkenburg, F.; Favier, R.; Federico, M.; Fenaux, P.; Fitzgibbon, J.; Flygare, J.; Foa, R.; Forrester, L.; Galacteros, F.; Garagiola, I.; Gardiner, C.; Garraud, O.; Geet, C. van; Geiger, H.; Geissler, J.; Germing, U.; Ghevaert, C.; Girelli, D.; Godeau, B.; Gokbuget, N.; Goldschmidt, H.; Goodeve, A.; Graf, T.; Graziadei, G.; Griesshammer, M.; Gruel, Y.; Guilhot, F.; Gunten, S. von; Gyssens, I.; Halter, J.; Harrison, C.; Harteveld, C.; Hellstrom-Lindberg, E.; Hermine, O.; Higgs, D.; Hillmen, P.; Hirsch, H.; Hoskin, P.; Huls, G.; Inati, A.; Johnson, P.; Kattamis, A.; Kiefel, V.; Kleanthous, M.; Klump, H.; Krause, D.; Hovinga, J.K.; Lacaud, G.; Lacroix-Desmazes, S.; Landman-Parker, J.; LeGouill, S.; Lenz, G.; Lilienfeld-Toal, M. von; Lindern, M. von; Lopez-Guillermo, A.; Lopriore, E.; Lozano, M.; MacIntyre, E.; Makris, M.; Makris, M.; Martens, J.; Mathas, S.; Matzdorff, A.; Medvinsky, A.; Menendez, P.; Migliaccio, A.R.; Miharada, K.; Mikulska, M.; Minard, V.; Montalban, C.; Montalembert, M. de; Montserrat, E.; Morange, P.E.; Mountford, J.; Muckenthaler, M.; Muller-Tidow, C.; Mumford, A.; Nadel, B.; Navarro, J.T.; Nemer, W. el; Noizat-Pirenne, F.; O'Mahony, B.; Oldenburg, J.; Olsson, M.; Oostendorp, R.; Palumbo, A.; Passamonti, F.; Patient, R.; Latour, R.P. de; Pflumio, F.; Pierelli, L.; Piga, A.; Pollard, D.; Raaijmakers, M.; Radford, J.; Rambach, R.; Rao, A.K.; Raslova, H.; Rebulla, P.; Rees, D.; Ribrag, V.; Rijneveld, A.; Rinalducci, S.; Robak, T.; Roberts, I.; Rodrigues, C.; Rosendaal, F.; Rosenwald, A.; Rule, S.; Russo, R.; Saglio, G.; Sanchez, M.; Scharf, R.E.; Schlenke, P.; Semple, J.; Sierra, J.; So-Osman, C.; Soria, J.M.; Stamatopoulos, K.; Stegmayr, B.; Stunnenberg, H.; Swinkels, D.; Barata, J.P.T.; Taghon, T.; Taher, A.; Terpos, E.; Thachil, J.; Tissot, J.D.; Touw, I.; Toye, A.; Trappe, R.; Traverse-Glehen, A.; Unal, S.; Vaulont, S.; Viprakasit, V.; Vitolo, U.; Wijk, R. van; Wojtowicz, A.; Zeerleder, S.; Zieger, B. & EHA Roadmap European Hematology Re (2016), The European Hematology Association Roadmap for European Hematology Research: a consensus document, Haematologica 101(2): 115-208.
- Evers, D.; Zwaginga, J.J.; Tijmensen, J.; Middelburg, R.A.; Haas, M. de; Vooght, K.M.K. de; Kerkhof, D. van de; Visser, O.; Pequeriaux, N.C.V.; Hudig, F. & Bom, J.G. van der (2016), Treatments for hematologic malignancies in contrast to those for solid cancers are associated with reduced red cell alloimmunization, Haematologica 102(1): 52-59.
- Evers, D.; Bom, J.G. van der; Tijmensen, J.; Middelburg, R.A.; Haas, M. de; Zalpuri, S.; Vooght, K.M.K. de; Kerkhof, D. van de; Visser, O.; Pequeriaux, N.C.V.; Hudig, F. & Zwaginga, J.J. (2016), Red cell alloimmunisation in patients with different types of infections, British Journal of Haematology 175(5): 956-966.
- Stolk, J.; Broekman, W.; Mauad, T.; Zwaginga, J.J.; Roelofs, H.; Fibbe, W.E.; Oostendorp, J.; Bajema, I.; Versteegh, M.I.M.; Taube, C. & Hiemstra, P.S. (2016), A phase I study for intravenous autologous mesenchymal stromal cell administration to patients with severe emphysema, QJM: An International Journal of Medicine 109(5): 331-336.
- Zeller, M.; Barty, R.L.; Elahie, A.; Dunbar, N.M.; Flanagan, P.; Garritsen, H.; Kutner, J.; Pagano, M.B.; Poglod, R.; Rogers, T.S.; Staves, J.; Wordragen, M. van; Zwaginga, J.; Heddle, N.M.; Yazer, M.H. & O Collaborative (2016), How Many AB Plasma Units Were Infused? The HABSWIN Study, Transfusion 56: 169A-169A.
- Netelenbos, T.; Oostrum, A. van; Rozier, Y.; Muijsenberg, J.; Overdevest, J.; Noort, A.; Spruitenburg, P. & Zwaginga, J.J. (2016), Improving collection efficiency during stem cell apheresis using a quick cell count, Bone Marrow Transplantation 51: S342-S343.
- Middelburg, R.A.; Carbaat-Ham, J.C.; Hesam, H.; Ragusi, M.A.A.D. & Zwaginga, J.J. (2016), Platelet function in adult ITP patients can be either increased or decreased, compared to healthy controls, and is associated with bleeding risk, Hematology 21(9): 549-551.
- Ostaijen-ten Dam, M.M. van; Prins, H.J.; Boerman, G.H.; Vervat, C.; Pende, D.; Putter, H.; Lankester, A.; Tol, M.J.D. van; Zwaginga, J.J. & Schilham, M.W. (2016), Preparation of Cytokine-activated NK Cells for Use in Adoptive Cell Therapy in Cancer Patients: Protocol Optimization and Therapeutic Potential, Journal of Immunotherapy 39(2): 90-100.
- Garde, M. van der; Hensbergen, Y. van; Brand, A.; Slot, M.C.; Graaf-Dijkstra, A. de; Mulder, A.; Watt, S.M. & Zwaginga, J.J. (2015), Thrombopoietin Treatment of One Graft in a Double Cord Blood Transplant Provides Early Platelet Recovery While Contributing to Long-Term Engraftment in NSG Mice, Stem Cells and Development 24(1): 67-76.
- Zwaginga, J.J.; Holt, B. van der; Boekhorst, P.A. te; Biemond, B.J.; Levin, M.D.; Griend, R. van der; Brand, A.; Zweegman, S.; Pruijt, H.F.M.; Novotny, V.M.J.; Vreugdenhil, A.; Groot, M.R. de; Weerdt, O. de; Pampus, E.C.M. van; Maanen-Lamme, T.M. van; Wittebol, S.; Schipperus, M.R.; Silbermann, M.H.; Huijgens, P.C.; Luten, M.; Hollestein, R.; Brakenhoff, J.A.C.; Schrama, J.G.; Valster, F.A.A.; Velders, G.A.; Koene, H.R. & Dutch HOVON 64 Study Grp (2015), Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients, Haematologica 100(3): E90-E92.
- Molendijk, I.; Bonsing, B.A.; Roelofs, H.; Peeters, K.C.; Wasser, M.N.; Veenendaal, R.A.; Zwaginga, J.J.; Verspaget, H.W.; Fibbe, W.E.; Meulen-de Jong, A.E. van der & Hommes, D.W. (2015), Unblinded Results from a dose-escalating placebo-controlled study with allogeneic bone marrow-derived mesenchymal stem cells for the treatment of refractory perianal fistulas in patients with Crohn's disease, Journal of Crohn's and Colitis 9: S254-S255.
- Bonten, T.N.; Snoep, J.D.; Assendelft, W.J.J.; Zwaginga, J.J.; Eikenboom, J.; Huisman, M.V.; Rosendaal, F.R. & Bom, J.G. van der (2015), Time-Dependent Effects of Aspirin on Blood Pressure and Morning Platelet Reactivity A Randomized Cross-Over Trial, Hypertension 65(4): 743-750.
- Henriquez, D.D.; Bloemenkamp, K.W.; Cessie, S. le; Zwart, J.; Roosmalen, J. van; Eikenboom, J.; So-Osman, C.; Watering, L. van de; Zwaginga, J.J.; Bom, J.G. van der & TeMpOH-1 Study Grp (2015), Timing of plasma transfusion and maternal mortality and severe maternal morbidity in women with persistent postpartum haemorrhage: the Tempoh-1 study, Journal of Thrombosis and Haemostasis 13: 86-86.
- Oostrum, A. van; Overdevest, J.; Noort, A. van; Fechter, M.; Brand, A.; Zwaginga, J.J. & Netelenbos, T. (2015), Feasibility of PBSC harvest on day 4 with the Spectra Optia in healthy stem cell donors, Bone Marrow Transplantation 50: S369-S370.
- Mann, I.; Rodrigo, S.F.; Ramshorst, J. van; Beeres, S.L.; Dibbets-Schneider, P.; Roos, A. de; Wolterbeek, R.; Zwaginga, J.J.; Fibbe, W.E.; Bax, J.J.; Schalij, M.J. & Atsma, D.E. (2015), Repeated Intramyocardial Bone Marrow Cell Injection in Previously Responding Patients With Refractory Angina Again Improves Myocardial Perfusion, Anginal Complaints, and Quality of Life, Circulation: Cardiovascular Interventions 8(8).
- Schonewille, H.; Prinsen-Zander, K.J.M.; Reijnart, M.; Watering, L.V. de; Zwaginga, J.J.; Meerman, R.H.; Kamp, I.L. van & Brand, A. (2015), Extended matched intrauterine transfusions reduce maternal Duffy, Kidd, and S antibody formation, Transfusion 55(12): 2912-2919.
- Garde, M. van der; Brand, A.; Slot, M.C.; Graaf-Dijkstra, A. de; Zwaginga, J.J. & Hensbergen, Y. van (2015), No Synergistic Effect of Cotransplantation of MSC and Ex Vivo TPO-Expanded CD34(+) Cord Blood Cells on Platelet Recovery and Bone Marrow Engraftment in NOD SCID Mice, Stem Cells and Development 24(12): 1448-1456.
- Garde, M. van der; Pel, M. van; Rivero, J.E.M.; Graaf-Dijkstra, A. de; Slot, M.C.; Kleinveld, Y.; Watt, S.M.; Roelofs, H. & Zwaginga, J.J. (2015), Direct Comparison of Wharton's Jelly and Bone Marrow-Derived Mesenchymal Stromal Cells to Enhance Engraftment of Cord Blood CD34(+) Transplants, Stem Cells and Development 24(22): 2649-2659.
- Molendijk, I.; Bonsing, B.A.; Roelofs, H.; Peeters, K.C.M.J.; Wasser, M.N.J.M.; Dijkstra, G.; Woude, C.J. van der; Duijvestein, M.; Veenendaal, R.A.; Zwaginga, J.J.; Verspaget, H.W.; Fibbe, W.E.; Meulen-de Jong, A.E. van der & Hommes, D.W. (2015), Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease.
- Molendijk, I.; Bonsing, B.A.; Roelofs, H.; Peeters, K.C.M.J.; Wasser, M.N.J.M.; Dijkstra, G.; Woude, C.J. van der; Veenendaal, R.A.; Zwaginga, J.J.; Verspaget, H.W.; Fibbe, W.E.; Meulen-de Jong AE van der & Hommes, D.W. (2015), Allogeneic bone marrow-derived mesenchymal stromal stem cells for the treatment of refractory perianal Crohn fistulas: a dose-escalating placebo-controlled study, Journal of Crohn's and Colitis 9: S32-S33.
- Henriquez, D.D.; Bloemenkamp, K.W.; Zwaginga, J.J.; Bom, J.G. van der & TeMpOH-1 Study Grp (2015), Volume of fluid resuscitation in women with persistent postpartum haemorrhage and total blood loss, maternal mortality and severe maternal morbidity, Journal of Thrombosis and Haemostasis 13: 971-971.
- Bontekoe, I.J.; Scharenberg, J.; Schonewille, H.; Zwaginga, J.J.; Brand, A.; Meer, P.F. van der & Korte, D. de (2015), A new preparation method for red blood cells for intrauterine transfusion enabling reduction of donor exposure, Transfusion 55(7): 1693-1699.
- Kreuger, A.L.; Middelburg, R.A.; Zwaginga, J.J.; Bom, J.G. van der & Kerkhoffs, J.L.H. (2015), Clinical practice of platelet transfusions in haemato-oncology, Vox Sanguinis 109(1): 91-94.
- Hensbergen, Y. van; Garde, M. van der; Brand, A.; Slot, M.C.; Graaf-Dijkstra, A. de; Watt, S. & Zwaginga, J.J. (2015), Cryopreservation of cord blood CD34+cells before or after thrombopoietin expansion differentially affects early platelet recovery in NOD SCID mice, Transfusion 55(7): 1772-1781.
- Bonten, T.N.; Saris, A.; Oostrom, M.J. van; Snoep, J.D.; Rosendaal, F.R.; Zwaginga, J.J.; Eikenboom, J.; Meer, P.F. van der & Bom, J.G. van der (2014), Effect of aspirin intake at bedtime versus on awakening on circadian rhythm of platelet reactivity A randomised cross-over trial, Thrombosis and Haemostasis 112(6): 1209-1218.
- Ramshorst, J. van; Beeres, S.L.M.A.; Rodrigo, S.F.; Dibbets-Schneider, P.; Scholte, A.J.; Fibbe, W.E.; Zwaginga, J.J.; Schalij, M.J.; Bax, J.J. & Atsma, D.E. (2014), Effect of intramyocardial bone marrow-derived mononuclear cell injection on cardiac sympathetic innervation in patients with chronic myocardial ischemia, International Journal of Cardiovascular Imaging 30(3): 583-589.
- Bleker-Grijsen, T.; Carlee, L.; Steeneveld, E.; Lommerse, I.; Roelofs, H.; Zwaginga, J.; Voermans, C. & Thijssen-Timmer, D. (2014), ENHANCED CELL RECOVERY RESULTING IN HIGHER YIELDS OF MSC WHEN USING THE COBE 2991 FOR CELL DENSITY SEPARATION OF BONE MARROW MATERIAL: A VALIDATION STUDY BETWEEN TWO MSC PRODUCTION CENTERS, Cytotherapy 16(4): S84-S84.
- Zalpuri, S.; Evers, D.; Zwaginga, J.J.; Schonewille, H.; Vooght, K.M.K. de; Cessie, S. le & Bom, J.G. van der (2014), Immunosuppressants and alloimmunization against red blood cell transfusions, Transfusion 54(8): 1981-1987.
- Zalpuri, S.; Middelburg, R.A.; Schonewille, H.; Vooght, K.M.K. de; Cessie, S. le; Bom, J.G. van der & Zwaginga, J.J. (2014), Intensive red blood cell transfusions and risk of alloimmunization, Transfusion 54(2): 278-284.
- Zeddies, S.; Jansen, S.B.G.; Summa, F. di; Geerts, D.; Zwaginga, J.J.; Schoot, C.E. van der; Lindern, M. von & Thijssen-Timmer, D.C. (2014), MEIS1 regulates early erythroid and megakaryocytic cell fate, Haematologica 99(10): 1555-1564.
- Rodrigo, S.F.; Ramshorst, J. van; Mann, I.; Leong, D.P.; Cannegieter, S.C.; Younis, I. al; Dibbets-Schneider, P.; Roos, A. de; Fibbe, W.E.; Zwaginga, J.J.; Bax, J.J.; Schalij, M.J.; Beeres, S.L. & Atsma, D.E. (2014), Predictors of response to intramyocardial bone marrow cell treatment in patients with refractory angina and chronic myocardial ischemia, International Journal of Cardiology 175(3): 539-544.
- Rodrigo, S.F.; Ramshorst, J. van; Hoogslag, G.E.; Boden, H.; Velders, M.A.; Cannegieter, S.C.; Roelofs, H.; Younis, I. al; Dibbets-Schneider, P.; Fibbe, W.E.; Zwaginga, J.J.; Bax, J.J.; Schalij, M.J.; Beeres, S.L. & Atsma, D.E. (2013), Intramyocardial Injection of Autologous Bone Marrow-Derived Ex Vivo Expanded Mesenchymal Stem Cells in Acute Myocardial Infarction Patients is Feasible and Safe up to 5 Years of Follow-up, Journal of Cardiovascular Translational Research 6(5): 816-825.
- Ramshorst, J. van; Rodrigo, S.F.; Beeres, S.L.M.A.; Fibbe, W.E.; Zwaginga, J.J.; Bax, J.J.; Schalij, M.J. & Atsma, D.E. (2013), Long term effects of intramyocardial bone marrow cell injection on anginal symptoms and quality of life in patients with chronic myocardial ischemia, International Journal of Cardiology 168(3): 3031-3032.
- Zalpuri, S.; Schonewille, H.; Middelburg, R.A.; Zwaginga, J.J. & Bom, J.G. van der (2013), MEDICATIONS AND THERAPIES AND THE OCCURRENCE OF ALLOIMMUNIZATION AGAINST RED BLOOD CELL TRANSFUSIONS, Vox Sanguinis 105: 259-259.
- Ball, L.M.; Bernardo, M.E.; Roelofs, H.; Tol, M.J.D. van; Contoli, B.; Zwaginga, J.J.; Avanzini, M.A.; Conforti, A.; Bertaina, A.; Giorgiani, G.; Jol-van der Zijde, C.M.; Zecca, M.; Blanc, K. le; Frassoni, F.; Egeler, R.M.; Fibbe, W.E.; Lankester, A.C. & Locatelli, F. (2013), Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease, British Journal of Haematology 163(4): 501-509.
- Gast-Bakker, D.H. de; Wilde, R.B.P. de; Hazekamp, M.G.; Sojak, V.; Zwaginga, J.J.; Wolterbeek, R.; Jonge, E. de & Gesink-van der Veer, B.J. (2013), Safety and effects of two red blood cell transfusion strategies in pediatric cardiac surgery patients: a randomized controlled trial, Intensive Care Medicine 39(11): 2011-2019.
- Bonten, T.; Snoep, J.D.; Assendelft, W.J.; Zwaginga, J.J.; Huisman, M.V.; Rosendaal, F.R.; Eikenboom, H.C.J. & Bom, J.G. van der (2013), Aspirin intake AM or PM?: effect on platelet reactivity in the morning, Journal of Thrombosis and Haemostasis 11: 759-759.
- Bonten, T.; Snoep, J.D.; Zwaginga, J.J.; Rosendaal, F.R.; Eikenboom, H.C.J. & Bom, J.G. van der (2013), Time dependent effect of aspirin intake on circadian rhythm of platelet reactivity: a pilot study, Journal of Thrombosis and Haemostasis 11: 1154-1155.
- Watt, S.M.; Gullo, F.; Garde, M. van der; Markeson, D.; Camicia, R.; Khoo, C.P. & Zwaginga, J.J. (2013), The angiogenic properties of mesenchymal stem/stromal cells and their therapeutic potential, British Medical Bulletin 108(1): 25-53.
- Porcelijn, L.; Oldert, G.; Huiskes, E.; Haas, M. de & Zwaginga, J.J. (2013), THE DIRECT MAIPA REVISITED FOR THE DETECTION OF PLATELET AUTOANTIBODIES, Vox Sanguinis 105: 243-244.
- Nordennen, J. van; Koopman-van Gemert, A.W.M.M.; So-Osman, C.; Zwaginga, J.J. & Nelissen, R.G.H.H. (2013), 'PRE-OPERATIVE IRON' USE AS BLOOD SPARING TECHNIQUE IN ORTHOPAEDIC SURGERY (THE POP-I STUDY), Vox Sanguinis 105: 267-267.
- Melief, S.M.; Zwaginga, J.J.; Fibbe, W.E. & Roelofs, H. (2013), Adipose Tissue-Derived Multipotent Stromal Cells Have a Higher Immunomodulatory Capacity Than Their Bone Marrow-Derived Counterparts, Stem Cells Translational Medicine 2(6): 455-463.
- Zalpuri, S.; Middelburg, R.A.; Watering, L.V. de; Vamvakas, E.; Zwaginga, J.J. & Born, J.G. van der (2013), Association Vs Causality in Transfusion Medicine: Understanding Multivariable Analysis in Prediction Vs Etiologic Research, Transfusion Medicine Reviews 27(2): 74-81.
- Reinders, M.E.J.; Roemeling-van Rhijn, M.; Khairoun, M.; Lievers, E.; Vries, D.K. de; Schaapherder, A.F.M.; Wong, S.W.S.; Zwaginga, J.J.; Duijs, J.M.; Zonneveld, A.J. van; Hoogduijn, M.J.; Fibbe, W.E.; Fijter, J.W. de; Kooten, C. van; Rabelink, T.J. & Roelofs, H. (2013), Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy, Cytotherapy 15(6): 663-672.
- Halteren, A.G.S. van; Rosier, P.; Kemps-Mols, B.; Vervat, C.; Pool, J.; Calkoen, F.; Zwaginga, J.; Fechter, M. & Tol, M.J.D. van (2013), Detection of male DNA in CD34+and CD34-cells derived from G-CSF-exposed female donors, Bone Marrow Transplantation 48: S68-S69.
- Bonten, T.N.; Snoep, J.D.; Assendelft, W.J.; Zwaginga, J.J.; Huisman, M.V.; Rosendaal, F.R.; Eikenboom, J. & Bom, J.G. van (2013), Does Aspirin Intake at Bedtime Decrease Blood Pressure and Morning Peak of Platelet Reactivity?: A Randomized Cross-over Trial, Circulation 128(24): 2716-2716.
- Deelder, C.C.; Middelburg, R.A.; Zwaginga, J.J. & Bom, J.G. van der (2013), DONOR SEX AND TRANSFUSION RECIPIENT MORTALITY - RESULTS FROM TWO HOSPITALS, Vox Sanguinis 105: 274-274.
- Zalpuri, S.; Schonewille, H.; Middelburg, R.; Watering, L. van de; Vooght, K. de; Zimring, J.; Bom, J.G. van der & Zwaginga, J.J. (2013), Effect of storage of red blood cells on alloimmunization, Transfusion 53(11): 2795-2800.
- Zalpuri, S.; Middelburg, R.A.; Watering, L. van de; Vamvakas, E.; Zwaginga, J.J. & Bom, J.G. van der (2013), ETIOLOGY AND PREDICTION RESEARCH, A CONFUSING DISTINCTION: RESULTS FROM ISBT 2012 CANCUN ATTENDEES' SURVEY, Vox Sanguinis 105: 35-36.
- Netelenbos, T.; Bouwsma, H.; Noort, F.A.; Groot, I. de; Fijter, J.W. de & Zwaginga, J.J. (2013), Immune adsorption of anti-A/B antibodies prior to ABO-mismatched kidney transplantation: The Leiden experience, Transfusion and Apheresis Science 48(2): 185-185.
- Middelburg, R.A.; Roest, M.; Ham, J.; Coccoris, M.; Zwaginga, J.J. & Meer, P.F. van der (2013), Flow cytometric assessment of agonist-induced P-selectin expression as a measure of platelet quality in stored platelet concentrates, Transfusion 53(8): 1780-1787.
- Stevanovic, S.; Bergen, C.A.M. van; Luxemburg-Heijs, S.A.P. van; Zouwen, B. van der; Jordanova, E.S.; Kruisselbrink, A.B.; Meent, M.V. de; Harskamp, J.C.; Claas, F.H.J.; Marijt, E.W.A.; Zwaginga, J.J.; Halkes, C.J.M.; Jedema, I.; Griffioen, M. & Falkenburg, J.H.F. (2013), HLA class II upregulation during viral infection leads to HLA-DP-directed graft-versus-host disease after CD4+donor lymphocyte infusion, Blood 122(11): 1963-1973.
- Zalpuri, S.; Zwaginga, J.J.; Cessie, S. le; Elshuis, J.; Schonewille, H. & Bom, J.G. van der (2012), Red-blood-cell alloimmunization and number of red-blood-cell transfusions.
- Zalpuri, S.; Zwaginga, J.J.; Cessie, S. le; Elshuis, J.; Schonewille, H. & Bom, J.G. van der (2012), Red-blood-cell alloimmunization and number of red-blood-cell transfusions, Vox Sanguinis 102(2): 144-149.
- Zalpuri, S.; Zwaginga, J.J. & Bom, J.G. van der (2012), Risk Factors for Alloimmunisation after red blood Cell Transfusions (R-FACT): a case cohort study., BMJ Open 2(3).
- Middelburg, R.A.; Roest, M.; Ham, J.; Coccoris, M.; Zwaginga, J.J. & Meer, P.F. van der (2012), Flow cytometric assessment of agonist-induced P-selectin expression as a measure of platelet quality in stored platelet concentrates., Transfusion.
- Rodrigo, S.F.; Ramshorst, J. van; Beeres, S.L.; Younis, I. al; Dibbets-Schneider, P.; Roos, A. de; Fibbe, W.E.; Zwaginga, J.J.; Schalij, M.J.; Bax, J.J. & Atsma, D.E. (2012), Intramyocardial injection of bone marrow mononuclear cells in chronic myocardial ischemia patients after previous placebo injection improves myocardial perfusion and anginal symptoms: An intra-patient comparison, American Heart Journal 164(5): 771-778.
- Ypma, P.F.; Kerkhoffs, J.L.H.; Hilten, J.A. van; Middelburg, R.A.; Coccoris, M.; Zwaginga, J.J.; Beckers, E.M.; Fijnheer, R.; Meer, P.F. van der & Brand, A. (2012), The observation of bleeding complications in haemato-oncological patients: stringent watching, relevant reporting, Transfusion Medicine 22(6): 426-431.
- Zeddies, S.; Jansen, S.; Nuernberg, S.; Summa, F. di; Ouwehand, W.H.; Zwaginga, J.J.; Lindern, M. von; Rendon, A.; Schoot, C.E. van der & Thijssen-Timmer, D.C. (2012), THE TRANSCRIPTION FACTOR MEIS1 REGULATES MEGAKARYOCYTE-ERYTHROCYTE FATE BY INDUCING FOG1 EXPRESSION, Experimental Hematology 40(8): S64-S65.
- Laan, A.M. van der; Hirsch, A.; Robbers, L.F.H.J.; Nijveldt, R.; Lommerse, I.; Delewi, R.; Vleuten, P.A. van der; Biemond, B.J.; Zwaginga, J.J.; Giessen, W.J. van der; Zijlstra, F.; Rossum, A.C. van; Voermans, C.; Schoot, C.E. van der; Piek, J.J. & Hebe Investigators (2012), A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction: Monocytes and myocardial infarction, American Heart Journal 163(1): 57-U83.
- Laan, A.M. van der; Hirsch, A.; Nijveldt, R.; Vleuten, P.A. van der; Giessen, W.J. van der; Doevendans, P.A.; Waltenberger, J.; Berg, J.M. ten; Aengevaeren, W.R.M.; Zwaginga, J.J.; Biemond, B.J.; Rossum, A.C. van; Tijssen, J.G.P.; Zijlstra, F. & Piek, J.J. (2012), Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results, Netherlands Heart Journal 20: 36-39.
- Boks, M.A.; Kager-Groenland, J.R.; Haasjes, M.S.P.; Zwaginga, J.J.; Ham, S.M. van & Brinke, A. ten (2012), IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction - A comparative study of human clinical-applicable DC.
- Hellingman, A.A.; Zwaginga, J.J.; Beem, R.T. van; Hamming, J.F.; Fibbe, W.E.; Quax, P.H.A.; Geutskens, S.B. & TeRM Smart Mix Consortium (2011), T-cell-pre-stimulated Monocytes Promote Neovascularisation in a Murine Hind Limb Ischaemia Model., European Journal of Vascular and Endovascular Surgery 41(3): 418-28.
- Gieger, C.; Radhakrishnan, A.; Cvejic, A.; Tang, W.H.; Porcu, E.; Pistis, G.; Serbanovic-Canic, J.; Elling, U.; Goodall, A.H.; Labrune, Y.; Lopez, L.M.; Magi, R.; Meacham, S.; Okada, Y.; Pirastu, N.; Sorice, R.; Teumer, A.; Voss, K.; Zhang, W.H.; Ramirez-Solis, R.; Bis, J.C.; Ellinghaus, D.; Gogele, M.; Hottenga, J.J.; Langenberg, C.; Kovacs, P.; O'Reilly, P.F.; Shin, S.Y.; Esko, T.; Hartiala, J.; Kanoni, S.; Murgia, F.; Parsa, A.; Stephens, J.; Harst, P. van der; Schoot, C.E. van der; Allayee, H.; Attwood, A.; Balkau, B.; Bastardot, F.; Basu, S.; Baumeister, S.E.; Biino, G.; Bomba, L.; Bonnefond, A.; Cambien, F.; Chambers, J.C.; Cucca, F.; D'Adamo, P.; Davies, G.; Boer, R.A. de; Geus, E.J.C. de; Doring, A.; Elliott, P.; Erdmann, J.; Evans, D.M.; Falchi, M.; Feng, W.; Folsom, A.R.; Frazer, I.H.; Gibson, Q.D.; Glazer, N.L.; Hammond, C.; Hartikainen, A.L.; Heckbert, S.R.; Hengstenberg, C.; Hersch, M.; Illig, T.; Loos, R.J.F.; Jolley, J.; Khaw, K.T.; Kuhnel, B.; Kyrtsonis, M.C.; Lagou, V.; Lloyd-Jones, H.; Lumley, T.; Mangino, M.; Maschio, A.; Leach, I.M.; McKnight, B.; Memari, Y.; Mitchell, B.D.; Montgomery, G.W.; Nakamura, Y.; Nauck, M.; Navis, G.; Nothlings, U.; Nolte, I.M.; Porteous, D.J.; Pouta, A.; Pramstaller, P.P.; Pullat, J.; Ring, S.M.; Rotter, J.I.; Ruggiero, D.; Ruokonen, A.; Sala, C.; Samani, N.J.; Sambrook, J.; Schlessinger, D.; Schreiber, S.; Schunkert, H.; Scott, J.; Smith, N.L.; Snieder, H.; Starr, J.M.; Stumvoll, M.; Takahashi, A.; Tang, W.H.W.; Taylor, K.; Tenesa, A.; Thein, S.L.; Tonjes, A.; Uda, M.; Ulivi, S.; Veldhuisen, D.J. van; Visscher, P.M.; Volker, U.; Wichmann, H.E.; Wiggins, K.L.; Willemsen, G.; Yang, T.P.; Zhao, J.H.; Zitting, P.; Bradley, J.R.; Dedoussis, G.V.; Gasparini, P.; Hazen, S.L.; Metspalu, A.; Pirastu, M.; Shuldiner, A.R.; Pelt, L.J. van; Zwaginga, J.J.; Boomsma, D.I.; Deary, I.J.; Franke, A.; Froguel, P.; Ganesh, S.K.; Jarvelin, M.R.; Martin, N.G.; Meisinger, C.; Psaty, B.M.; Spector, T.D.; Wareham, N.J.; Akkerman, J.W.N.; Ciullo, M.; Deloukas, P.; Greinacher, A.; Jupe, S.; Kamatani, N.; Khadake, J.; Kooner, J.S.; Penninger, J.; Prokopenko, I.; Stemple, D.; Toniolo, D.; Wernisch, L.; Sanna, S.; Hicks, A.A.; Rendon, A.; Ferreira, M.A.; Ouwehand, W.H. & Soranzo, N. (2011), New gene functions in megakaryopoiesis and platelet formation, Nature 480(7376): 201-208.
- Hirsch, A.; Nijveldt, R.; Vleuten, P.A. van der; Tijssen, J.G.P.; Giessen, W.J. van der; Tio, R.A.; Waltenberger, J.; Berg, J.M. ten; Doevendans, P.A.; Aengevaeren, W.R.M.; Zwaginga, J.J.; Biemond, B.J.; Rossum, A.C. van; Piek, J.J.; Zijlstra, F. & HEBE Investigators (2011), Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial, European Heart Journal 32(14): 1736-1747.
- Roest, M.; Reininger, A.; Zwaginga, J.J.; King, M.R.; Heemskerk, J.W.M. & Biorheology Subcomm Ssc Isth (2011), Flow chamber-based assays to measure thrombus formation in vitro: requirements for standardization.
- Heemskerk, J.W.M.; Sakariassen, K.S.; Zwaginga, J.J.; Brass, L.F.; Jackson, S.P.; Farndale, R.W. & ISTH (2011), Collagen surfaces to measure thrombus formation under flow: possibilities for standardization.
- Staal, F.J.T.; Baum, C.; Cowan, C.; Dzierzak, E.; Hacein-Bey-Abina, S.; Karlsson, S.; Lapidot, T.; Lemischka, I.; Mendez-Ferrer, S.; Mikkers, H.; Moore, K.; Moreno, E.; Mummery, C.L.; Robin, C.; Suda, T.; Pel, M. van; Brink, G.V.; Zwaginga, J.J. & Fibbe, W.E. (2011), Stem cell self-renewal: lessons from bone marrow, gut and iPS toward clinical applications, Leukemia 25(7): 1095-1102.
- Staal, F.J.T.; Baum, C.; Cowan, C.; Dzierzak, E.; Hacein-Bey-Abina, S.; Karlsson, S.; Lapidot, T.; Lemischka, I.; Mendez-Ferrer, S.; Mikkers, H.; Moore, K.; Moreno, E.; Mummery, C.L.; Robin, C.; Suda, T.; Pel, M. van; Brink, G.V.; Zwaginga, J.J. & Fibbe, W.E. (2011), Stem cell self-renewal: lessons from bone marrow, gut and iPS toward clinical applications., Leukemia 25(7): 1095-102.
- Hellingman, A.A.; Zwaginga, J.J.; Beem, R.T. van; Hamming, J.F.; Fibbe, W.E.; Quax, P.H.A.; Geutskens, S.B. & TeRM Smart Mix Consortium (2011), T-cell-pre-stimulated Monocytes Promote Neovascularisation in a Murine Hind Limb Ischaemia Model.
- Ball, L.M.; Bernardo, M.E.; Tol, M.J.D. van; Giorgiani, G.; Roelofs, H.; Cometa, A.M.; Bertaina, A.; Zwaginga, J.J.; Zijde, E.J. van de; Avanzini, M.A.; Blanc, K. le; Ringden, O.; Frassoni, F.; Fibbe, W.E.; Egeler, M.; Lankester, A.C. & Locatelli, F. (2011), Mesenchymal stromal cells are highly effective in steroid-refractory, grade III-IV acute graft-versus-host disease in children, Bone Marrow Transplantation 46: S6S7.
- Ramshorst, J. van; Antoni, M.L.; Beeres, S.L.M.A.; Roes, S.D.; Delgado, V.; Rodrigo, S.F.; Roos, A. de; Holman, E.R.; Fibbe, W.E.; Lamb, H.J.; Zwaginga, J.J.; Boersma, E.; Wall, E.E. van der; Schalij, M.J.; Atsma, D.E. & Bax, J.J. (2011), Intramyocardial Bone Marrow-Derived Mononuclear Cell Injection for Chronic Myocardial Ischemia The Effect on Diastolic Function, Circulation: Cardiovascular Imaging 4(2): 122-129.
- Ramshorst, J. van; Antoni, M.L.; Beeres, S.L.M.A.; Roes, S.D.; Delgado, V.; Rodrigo, S.F.; Roos, A. de; Holman, E.R.; Fibbe, W.E.; Lamb, H.J.; Zwaginga, J.J.; Boersma, E.; Wall, E.E. van der; Schalij, M.J.; Atsma, D.E. & Bax, J.J. (2011), Intramyocardial Bone Marrow-Derived Mononuclear Cell Injection for Chronic Myocardial Ischemia: the Effect on Diastolic Function., Circulation: Cardiovascular Imaging.
- Snoep, J.D.; Eikenboom, J.C.J.; Zwaginga, J.J.; Roest, M.; Patrono, C.; Rocca, B.; Petrucci, G.; Rosendaal, F.R. & Bom, J.G. van der (2011), Platelet reactivity and recurrent cardiovascular events in patients with stable cardiovascular disease using aspirin: a head-to-head comparison of different tests.
- Zeddies, S.; Jansen, S.; Summa, F. di; Klamer, S.; Kleier, M.; Zwaginga, J.J.; Lindern, M. von; Schoot, C.E. van der & Thijssen-Timmer, D.C. (2011), MEIS1 Regulates Early Erythroid and Megakaryocytic Lineage Decision, Blood 118(21): 1020-1020.
- Ball, L.M.; Bernardo, M.E.; Zwaginga, J.J.; Tol, M. van; Cometa, A.; Roelofs, H.; Giorgiani, G.; Jol-van der Zijde, C.M.; Avanzini, M.A.; Blanc, K. le; Bertaina, A.; Frassoni, F.; Fibbe, W.E.; Ringden, O.; Egeler, R.M.; Locatelli, F. & Lankester, A. (2010), Early Intervention with Mesenchymal Stromal Cells for Refractory Grade III-IV Graft Versus Host Disease In Children Results In Excellent Long Term Outcome., Blood 116(21): 965-965.
- Zalpuri, S.; Zwaginga, J.J.; Elshuis, J.; Vries, R.R.P. de; Brand, A.; Schonewille, H. & Bom, J.G. van der (2010), CUMULATIVE INCIDENCE OF RED BLOOD CELL ALLOIMMUNIZATION, Vox Sanguinis 99: 453-453.
- Ball, L.M.; Bernardo, M.E.; Tol, M.J.D. van; Avanzini, M.A.; Lankester, A.C.; Roelofs, H.; Giorgiani, G.; Zwaginga, J.J.; Blanc, K. le; Fibbe, W.E.; Egeler, R.M. & Locatelli, F. (2010), Children responding to treatment with mesenchymal stromal cells for refractory severe graft-versus-host disease have excellent long-term outcome, Bone Marrow Transplantation 45: S261S261.
- Zwaginga, J.J.; Holt, R. van der; Biemond, B.J.; Boekhorst, P.A.W.T.; Levin, M.; Vreughdenhil, A.; Huijgens, P.C.; Brand, A.; Griend, R. van der; Luten, M.; Pruijt, H.; Weerdt, O. de; Pampus, E. van; Zweegman, S.; Hollestein, R. & Koene, H.R. (2010), Interim Analysis on a Dutch HOVON Multicenter Randomized Open Label Phase II Trial on 3 Rituximab Dosing Schemes In Chronic ITP Patients., Blood 116(21): 1042-1042.
- Hellingman, A.A.; Geutskens, S.B.; Seghers, L.; Vries, M.R. de; Zonneveld, A.J. van; Schoot, C.E. van der; Hamming, J.F.; Quax, P.H.A. & Zwaginga, J.J. (2010), Monocytes as cellular therapy for vascular regeneration, British Journal of Surgery 97: S37S37.
- Ball, L.M.; Bernardo, M.E.; Tol, M.J.D. van; Avanzini, M.A.; Lankester, A.C.; Roelofs, H.; Giorgiani, G.; Zwaginga, J.J.; Blanc, K. le; Fibbe, W.E.; Egeler, R.M. & Locatelli, F. (2010), Children responding to treatment with mesenchymal stromal cells for refractory severe graft-versus-host disease have excellent long-term outcome, Bone Marrow Transplantation 45: S261S261.
- Ball, L.M.; Schweizer, J.; Lankester, A.; Bernardo, M.E.; Tol, M.J.D. van; Roelofs, H.; Zwaginga, J.J.; Fibbe, W.E.; Locatelli, F. & Egeler, R.M. (2010), Gastrointestinal steroid refractory GvHD in children successfully treated with mesenchymal stromal cells cannot be solely assessed by clinical response, Bone Marrow Transplantation 45: S132S133.
- Ball, L.M.; Bernardo, M.E.; Tol, M.J.D. van; Roelofs, H.; Zwaginga, J.J.; Locatelli, F.; Fibbe, W.E. & Egeler, R.M. (2010), Multiple infusions of haploidentical mesenchymal stromal cells are not immunogenic in children undergoing myeloablative stem cell transplantation, Bone Marrow Transplantation 45: S382S382.
- Freyer, J.; Wagner, A.K.; Schunkert, H.; Zwaginga, J.J.; Aherrahrou, Z.; Linsel-Nitschke, P. & Erdmann, J. (2010), MRAS - A STRONG CANDIDATE GENE (SCG) FOR CORONARY ARTERY DISEASE (CAD), Atherosclerosis. Supplements 11(2): 36-36.
- Brinke, A. ten; Schijndel, G. van; Visser, R.; Gruijl, T.D. de; Zwaginga, J.J. & Ham, S.M. van (2010), Monophosphoryl lipid A plus IFN gamma maturation of dendritic cells induces antigen-specific CD8(+) cytotoxic T cells with high cytolytic potential, Cancer Immunology, Immunotherapy 59(8): 1185-1195.
- Duijvestein, M.; Vos, A.C.W.; Roelofs, H.; Wildenberg, M.E.; Wendrich, B.B.; Verspaget, H.W.; Kooy-Winkelaar, E.M.C.; Koning, F.; Zwaginga, J.J.; Fidder, H.H.; Verhaar, A.P.; Fibbe, W.E.; Brink, G.R. van den & Hommes, D.W. (2010), Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study, Gut 59(12): 1662-1669.
- Kerkhoffs, J.L.H.; Putten, W.L.J. van; Novotny, V.M.J.; Boekhorst, P.A.W.T.; Schipperus, M.R.; Zwaginga, J.J.; Pampus, L.C.M. van; Greef, G.E. de; Luten, M.; Huijgens, P.C.; Brand, A.; Rhenen, D.J. van & Dutch Belgian HOVON Cooperative Gr (2010), Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction, British Journal of Haematology 150(2): 209-217.
- Boks, M.A.; Zwaginga, J.J.; Ham, S.M. van & Brinke, A. ten (2010), An Optimized CFSE-based T-cell Suppression Assay to Evaluate the Suppressive Capacity of Regulatory T-Cells Induced by Human Tolerogenic Dendritic Cells, Scandinavian Journal of Immunology 72(2): 158-168.
- Snoep, J.D.; Gaussem, P.; Eikenboom, J.C.J.; Emmerich, J.; Zwaginga, J.J.; Holmes, C.E.; Vos, H.L.; Groot, P.G. de; Herrington, D.M.; Bray, P.F.; Rosendaal, F.R. & Bom, J.G. van der (2010), The minor allele of GP6 T13254C is associated with decreased platelet activation and a reduced risk of recurrent cardiovascular events and mortality: results from the SMILE-Platelets project, Journal of Thrombosis and Haemostasis 8(11): 2377-2384.
- Snoep, J.D.; Gaussem, P.; Eikenboom, J.C.J.; Emmerich, J.; Zwaginga, J.J.; Holmes, C.E.; Vos, H.L.; Groot, P.G. de; Herrington, D.M.; Bray, P.F.; Rosendaal, F.R. & Bom, J.G. van der (2010), The minor allele of GP6 T13254C is associated with decreased platelet activation and a reduced risk of recurrent cardiovascular events and mortality: results from the SMILE-Platelets project., Journal of Thrombosis and Haemostasis 8(11): 2377-84.
- Vrielink H, Meijer B, van 't Ende E, Ball LM, Brand A & Zwaginga JJ (2009), Granulocyte transfusions for pediatric patients and the establishment of national treatment guidelines and donor registry, Transfusion and Apheresis Science 41(1): 73-76.
- van Ramshorst J, Bax JJ, Beeres SLMA, Dibbets-Schneider P, Roes SD, Stokkel MPM, de Roos A, Fibbe WE, Zwaginga JJ, Boersma E, Schalij MJ & Atsma DE (2009), Intramyocardial Bone Marrow Cell Injection for Chronic Myocardial Ischemia A Randomized Controlled Trial, Journal of the American Medical Association 301(19): 1997-2004.
- van Gils JM, Zwaginga JJ & Hordijk PL (2009), Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases, Journal of Leukocyte Biology 85(2): 195-204.
- Ganesh SK, Zakai NA, van Rooij FJA, Soranzo N, Smith AV, Nalls MA, Chen MH, Kottgen A, Glazer NL, Dehghan A, Kuhnel B, Aspelund T, Yang Q, Tanaka T, Jaffe A, Bis JCM, Verwoert GC, Teumer A, Fox CS, Guralnik JM, Ehret GB, Rice K, Felix JF, Rendon A, Eiriksdottir G, Levy D, Patel KV, Boerwinkle E, Rotter JI, Hofman A, Sambrook JG, Hernandez DG, Zheng G, Bandinelli S, Singleton AB, Coresh J, Lumley T, Uitterlinden AG, vanGils JM & Launer LJ (2009), Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium, Nature Genetics 41(11): 1191U48.
- Zwaginga JJ (2009), Leukocytapheresis: A procedure gaining ground?, Transfusion and Apheresis Science 40(2): 133-133.
- van Gils JM, Stutterheim J, van Duijn TJ, Zwaginga JJ, Porcelijn L, de Haas M & Hordijk PL (2009), HPA-1a alloantibodies reduce endothelial cell spreading and monolayer integrity, Molecular Immunology 46(3): 406-415.
- O'Connor MN, Salles II, Cvejic A, Watkins NA, Walker A, Garner SF, Jones CI, Macaulay IC, Steward M & Zwaginga JJ (2009), Functional genomics in zebrafish permits rapid characterization of novel platelet membrane proteins, Blood 113(19): 4754-4762.
- Geutskens SB, Hellingman AW, van Beem RT, Seghers L, de Vries MR, van Zonneveld AJ, van den Elsen PJ, van der Schoot CE, Quax PHA & Zwaginga JJ (2009), TRANSFUSION OF PRO-ARTERIOGENIC MONOCYTES AS CELLULAR THERAPY FOR VASCULAR REGENERATION, Experimental Hematology 37(9): S8S8.
- Kerkhoffs JH, Novotny VM, Boekhorst PAT, Schipperus MR, Zwaginga JJ, van Pampus L, van Putten WL, Huijgens PC, Brand A & van Rhenen DJ (2009), Clinical Effectiveness and Safety of Pooled, Random Donor Platelet Concentrates, Leucoreduced and Stored up to Seven Days in Either Plasma or Additive Solution with and Without Pathogen Reduction in Hemato-oncological Patients, Transfusion 49: 2A3A.
- van Beem RT, Verloop RE, Koolwijk P, van Hinsbergh VWM & Zwaginga JJ (2009), Blood outgrowth endothelial cells from cord blood and peripheral blood: angiogenesis-related characteristics in vitro: reply to rebuttal, Journal of Thrombosis and Haemostasis 7(3): 506-508.
- Van Beem RT, Verloop RE, Kleijer M, Noort WA, Loof N, Koolwijk P, Van der Schoot CE, Van Hinsbergh VWM & Zwaginga JJ (2009), Blood outgrowth endothelial cells from cord blood and peripheral blood: angiogenesis-related characteristics in vitro, Journal of Thrombosis and Haemostasis 7(1): 217-226.
- van Ramshorst J, Bax JJ, Beeres SL, Dibbets-Schneider P, Roes SD, Stokkel MP, de Roos A, Fibbe WE, Zwaginga JJ, Boersma E, Schalij MJ & Atsma DE (2009), Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial., Journal of the American Medical Association 301(19): 1997-2004.
- de Jager SC, Canté-Barrett K, Bot I, Husberg C, van Puijvelde GH, van Santbrink PJ, Yndestad A, van den Oever JM, Kuiper J, van Berkel TJ, Lipp M, Zwaginga JJ, Fibbe WE, Aukrust P & Biessen EA (2009), Impaired effector memory T-cell regulation facilitates graft versus host disease in CCR7-deficient bone marrow transplant chimeras.
- de Jager SCA, Cante-Barrett K, Bot I, Husberg C, van Puijvelde GH, van Santbrink PJ, Yndestad A, van den Oever JME, Kuiper J & van Berkel TJC (2009), Impaired Effector Memory T-Cell Regulation Facilitates Graft Versus Host Disease in CCR7-Deficient Bone Marrow Transplant Chimeras, Transplantation 88(5): 631-639.
- van Beem RT, Nur E, Zwaginga JJ, Landburg PP, van Beers EJ, Duits AJ, Brandjes DP, Lommerse I, de Boer HC, van der Schoot CE, Schnog JJB & Biemond BJ (2009), Elevated endothelial progenitor cells during painful sickle cell crisis, Experimental Hematology 37(9): 1054-1059.
- Engelse MA, Loomans CJ, Oostendorp J, Ringers J, van Rossenberg EH, Steeneveld E, Overdevest JJ, Guchelaar HJ, van Bockel JH, Romijn HA, Fibbe WE, Zwaginga JJ, Rabelink TJ & de Koning EJ (2009), Initiation of a islet isolation program in The Netherlands, Xenotransplantation 16(5): 398-398.
- Tijssen MR, van Hennik PB, di Summa F, Zwaginga JJ, van der Schoot CE & Voermans C (2008), Transplantation of human peripheral blood CD34-positive cells in combination with ex vivo generated megakaryocytes results in fast platelet formation in NOD/SCID mice, Leukemia 22(1).
- van Beem RT, Noort WA, Voermans C, Kleijer M, ten Brinke A, van Ham SM, van der Schoot CE & Zwaginga JJ (2008), The presence of activated CD4(+) T cells is essential for the formation of colony-forming unit-endothelial cells by CD14(+) cells, Journal of Immunology 180(7).
- Tijssen MR, di Summa F, van den Oudenrijn S, Zwaginga JJ, van der Schoot CE, Voermans C & de Haas M (2008), Functional analysis of single amino-acid mutations in the thrombopoietin-receptor Mpl underlying congenital amegakaryocytic thrombocytopenia, British Journal of Haematology 141(6).
- van Gils JM, Martins PADC, Mol A, Hordijk PL & Zwaginga JJ (2008), Transendothelial migration drives dissociation of platelet-monocyte complexes, Thrombosis and Haemostasis 100(2).
- van Walraven SM, Zwaginga JJ, Kollen WJW, Bongaerts R, Brand A & Ball LM (2008), Pre-emptive donor granulocyte transfusions permit allogeneic stem cell transplantation in a child with progressive treatment resistant invasive pulmonary aspergillosis, Bone Marrow Transplantation 41.
- Kraus SE, Zwaginga JJ & Hensbergen Y (2008), Stem cell - Platelet complexes in stem cell products, Vox Sanguinis 95.
- Martins PD, Garcia-Vallejo JJ, van Thienen JV, Fernandez-Borja M, van Gils JM, Beckers C, Horrevoets AJ, Hordijk PL & Zwaginga JJ (2007), P-selectin glycoprotein ligand-1 is expressed on endothelial cells and mediates monocyte adhesion to activated endothelium, Arteriosclerosis, Thrombosis, and Vascular Biology 27(5).
- Zwaginga JJ, Sakarjassen KS, King MR, Diacovo TG, Grabowski EF, Nash G, Hoylaerts M & Heemskerk JWM (2007), Can blood flow assays help to identify clinically relevant differences in von Willebrand factor functionality in von Willebrand disease types 1-3?, Journal of Thrombosis and Haemostasis 5(12).
- ten Brinke A, Karsten ML, Dieker MC, Zwaginga JJ & van Ham SM (2007), The clinical grade maturation cocktail monophosphoryl lipid A plus IFN gamma generates monocyte-derived dendritic cells with the capacity to migrate and induce Th1 polarization, Vaccine 25(41).
- Macaulay IC, Tijssen MR, Thijssen-Timmer DC, Gusnanto A, Steward M, Burns P, Langford CF, Ellis PD, Dudbridge F, Zwaginga JJ, Watkins NA, van der Schoot CE & Ouwehand WH (2007), Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins, Blood 109(8).
- Martins PAD, van Gils JM, Mol A, Hordijk PL & Zwaginga JJ (2006), Platelet binding to monocytes increases the adhesive properties of monocytes by up-regulating the expression and functionality of beta(1) and B-2 integrins, Journal of Leukocyte Biology 79(3).
- Brandsma D, Ulfman L, Reijneveld JC, Bracke M, Taphoorn MJB, Zwaginga JJ, Gebbink MFB, de Boer H, Koenderman L & Voest EE (2006), Constitutive integrin activation on tumor cells contributes to progression of leptomeningeal metastases, Neuro-Oncology 8(2).
- Stevens W, Koene H, Zwaginga JJ & Vreugdenhil G (2006), Chronic idiopathic thrombocytopenic purpura: present strategy, guidelines and new insights, Netherlands Journal of Medicine 64(10).
- Tijssen MR, Van Hennik PB, Di Summa F, Hordijk PL, Zwaginga JJ, Van der Schoot CE & Voermans C (2006), Transplantation of human peripheral blood CD34-Positive cells in combination with ex vivo expanded megakaryocytes results in fast platelet formation in NOD/SCID mice., Blood 108(11).
- Zwaginga JJ, Sakariassen KS, Nash G, King MR, Heemskerk JW, Frojmovic M & Hoylaerts MF (2006), Flow-based assays for global assessment of hemostasis. Part 2: current methods and considerations for the future, Journal of Thrombosis and Haemostasis 4(12).
- Newland A, Caulier MT, Kappers-Klunne M, Schipperus MR, Lefrere F, Zwaginga JJ, Christal J, Chen CF & Nichol JL (2006), An open-label, unit dose-finding study of AMG 531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpura, British Journal of Haematology 135(4).
- Zwaginga JJ, Nash G, King MR, Heemskerk JWM, Frojmovic M, Hoylaerts MF & Sakariassen KS (2006), Flow-based assays for global assessment of hemostasis. Part 1: biorheologic considerations, Journal of Thrombosis and Haemostasis 4(11).
- Tijssen MR, van der Schoot E, Voermans C & Zwaginga JJ (2006), Clinical approaches involving thrombopoietin to shorten the period of thrombocytopenia after high-dose chemotherapy, Transfusion Medicine Reviews 20(4).
- ten Brinke A, Karsten ML, Dieker MC, Zwaginga JJ, Vrielink H & van Ham SM (2006), Generation of dendritic cells for immunotherapy is minimally impaired by granulocytes in the monocyte preparation, Immunobiology 211(6-8).
- de Boer HC, Verseyden C, Ulfman LH, Zwaginga JJ, Bot I, Biessen EA, Rabelink TJ & van Zonneveld AJ (2006), Fibrin and activated platelets cooperatively guide stem cells to a vascular injury and promote differentiation towards an endothelial cell phenotype, Arteriosclerosis, Thrombosis, and Vascular Biology 26(7).
- Martins PD & Zwaginga JJ (2005), Leukocyte-platelet aggregates: new particles reflecting and effecting cardiovascular disease, Thrombosis and Haemostasis 94(6).
- de Boer HC, Verseyden C, Loomans CJ, Ulfman LF, Zwaginga JJ, Rabelink TJ & van Zonneveld AJ (2004), Activated platelets provide signals for circulating CD34(+) cells to home to sites of vascular injury and differentiate into endothelial cells, Circulation 110(17).
- Bisoendial RJ, Zwaginga JJ, van den Bogaard B, Reijns T, Meijers JC, Levi M, Kastelein JJ & Stroes ES (2003), C-reactive protein infusion has a direct procoagulant effect in humans in vivo, Circulation 108(17).
- Brandsma D, Reijneveld JC, Taphoorn MJB, de Boer HC, Gebbink MFBG, Ulfman LH, Zwaginga JJ & Voest EE (2002), Vascular cell adhesion molecule-1 is a key adhesion molecule in melanoma cell adhesion to the leptomeninges, Laboratory Investigation 82(11).
- Medical Advisory Board (Single event)
- Medical Consultant
- National representative in the JACIE Europe board
- Member Medical Advisory Board
- Medical Advisory Board (Single event)
- Chairman: Transfusion Reaction in Patients
- Advisor Editorial Board
- Board member / treasurer